|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the quarterly period ended September 30, 2005 | ||
| or | ||
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
| For the transition period from to | ||
|
Delaware
|
81-0597059 | |
|
(State or other jurisdiction of
Incorporation or Organization) |
(I.R.S. Employer
Identification Number) |
| Page | ||||
| PART I FINANCIAL INFORMATION | ||||
| 2 | ||||
| 25 | ||||
| 41 | ||||
| 42 | ||||
| PART II OTHER INFORMATION | ||||
| 42 | ||||
| 42 | ||||
| 43 | ||||
| 45 | ||||
i
| Item 1. | Consolidated Financial Statements |
| Three Months Ended | |||||||||
| September 30, | September 24, | ||||||||
| 2005 | 2004 | ||||||||
| (Unaudited) | |||||||||
| (In millions, except per share | |||||||||
| amounts) | |||||||||
|
Sales
|
$ | 2,917 | $ | 2,739 | |||||
|
Cost of sales
|
2,623 | 2,458 | |||||||
|
Gross profit
|
294 | 281 | |||||||
|
Administrative and selling expenses
|
135 | 130 | |||||||
|
Research and development expenses
|
43 | 36 | |||||||
|
Amortization of intangible assets
|
8 | 8 | |||||||
|
Restructuring charges and asset impairments
|
35 | 5 | |||||||
|
Other (income) expense net
|
(1 | ) | 7 | ||||||
|
Operating income
|
74 | 95 | |||||||
|
Interest expense net
|
59 | 59 | |||||||
|
Accounts receivable securitization costs
|
| 1 | |||||||
|
Earnings before income taxes
|
15 | 35 | |||||||
|
Income tax expense
|
5 | 22 | |||||||
|
Net earnings
|
$ | 10 | $ | 13 | |||||
|
Basic earnings per share:
|
|||||||||
|
Earnings per share
|
$ | 0.10 | $ | 0.13 | |||||
|
Weighted average shares
|
99.1 | 98.9 | |||||||
|
Diluted earnings per share:
|
|||||||||
|
Earnings per share
|
$ | 0.10 | $ | 0.13 | |||||
|
Weighted average shares
|
103.1 | 101.2 | |||||||
2
Nine Months Ended
September 30,
September 24,
2005
2004
(Unaudited)
(In millions, except per share
amounts)
$
9,507
$
8,825
8,443
7,840
1,064
985
397
386
149
115
24
25
56
18
11
(9
)
427
450
171
181
7
48
2
2
247
219
102
128
$
145
$
91
$
1.46
$
0.93
99.0
97.4
$
1.42
$
0.91
102.0
100.2
3
As of
September 30,
December 31,
2005
2004
(Unaudited)
(Dollars in millions)
Assets
$
300
$
790
17
19
1,959
1,813
656
684
83
34
162
176
3,177
3,516
2,405
2,635
2,357
2,357
740
765
214
190
120
91
577
560
$
9,590
$
10,114
Liabilities, Minority Interests and Stockholders
Equity
$
38
$
40
17
19
1,721
1,887
285
309
242
233
995
992
3,298
3,480
2,776
3,122
930
959
715
843
261
268
307
272
8,287
8,944
56
65
1
1
1,139
1,131
73
(72
)
34
45
1,247
1,105
$
9,590
$
10,114
4
Nine Months Ended
September 30,
September 24,
2005
2004
(Unaudited)
(Dollars in millions)
$
145
$
91
380
366
(130
)
(35
)
10
7
15
1
7
48
(19
)
5
33
38
(291
)
(582
)
(8
)
(31
)
(62
)
25
(39
)
(13
)
81
116
122
36
(281
)
(248
)
(3
)
(5
)
(8
)
4
79
(288
)
(174
)
(1
)
6
1,313
1,290
(1,601
)
(1,855
)
(4
)
(7
)
143
635
(143
)
(319
)
2
(291
)
(250
)
(33
)
(2
)
(490
)
(390
)
790
828
$
300
$
438
5
| 1. | Description of Business |
| 2. | Basis of Presentation |
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 24, | September 30, | September 24, | |||||||||||||
| 2005 | 2004 | 2005 | 2004 | |||||||||||||
| (In millions) | ||||||||||||||||
|
Weighted average shares outstanding
|
99.1 | 98.9 | 99.0 | 97.4 | ||||||||||||
|
Effect of dilutive securities
|
4.0 | 2.3 | 3.0 | 2.8 | ||||||||||||
|
Diluted shares outstanding
|
103.1 | 101.2 | 102.0 | 100.2 | ||||||||||||
6
Changes in
Estimates and
Current
Used for
Effects of
Beginning
Period
Purposes
Foreign Currency
Ending
Balance
Accruals
Intended
Translation
Balance
(Dollars in millions)
$
110
$
16
$
(10
)
$
(6
)
$
110
110
47
(27
)
(20
)
110
92
16
(9
)
(4
)
95
74
49
(23
)
(5
)
95
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | ||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
| (In millions, except per share amounts) | |||||||||||||||||
|
Net earnings, as reported
|
$ | 10 | $ | 13 | $ | 145 | $ | 91 | |||||||||
|
Deduct: Stock-based compensation under SFAS 123 fair value
method, net of related tax effects
|
| (2 | ) | (4 | ) | (6 | ) | ||||||||||
|
Adjusted net earnings, fair value method
|
$ | 10 | $ | 11 | $ | 141 | $ | 85 | |||||||||
|
Basic earnings per share:
|
|||||||||||||||||
|
As reported
|
$ | 0.10 | $ | 0.13 | $ | 1.46 | $ | 0.93 | |||||||||
|
Pro forma
|
$ | 0.10 | $ | 0.11 | $ | 1.42 | $ | 0.87 | |||||||||
|
Diluted earnings per share:
|
|||||||||||||||||
|
As reported
|
$ | 0.10 | $ | 0.13 | $ | 1.42 | $ | 0.91 | |||||||||
|
Pro forma
|
$ | 0.10 | $ | 0.11 | $ | 1.38 | $ | 0.85 | |||||||||
7
Three Months Ended
Nine Months Ended
September 30,
September 24,
September 30,
September 24,
2005
2004
2005
2004
(Dollars in millions)
$
10
$
13
$
145
$
91
15
34
(51
)
(4
)
10
(2
)
40
7
$
35
$
45
$
134
$
94
| 3. | Subsequent Event |
8
| 4. | Acquisition and Divestitures |
| 5. | Restructuring Charges and Asset Impairments |
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | ||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
| (Dollars in millions) | |||||||||||||||||
|
Severance and other charges
|
$ | 32 | $ | 5 | $ | 53 | $ | 17 | |||||||||
|
Asset impairments related to restructuring activities
|
1 | | 3 | 1 | |||||||||||||
|
Curtailment gains
|
(10 | ) | | (12 | ) | | |||||||||||
|
Total restructuring charges
|
23 | 5 | 44 | 18 | |||||||||||||
|
Other asset impairments
|
12 | | 12 | | |||||||||||||
|
Total restructuring charges and asset impairments
|
$ | 35 | $ | 5 | $ | 56 | $ | 18 | |||||||||
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | ||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
| (Dollars in millions) | |||||||||||||||||
|
Chassis Systems
|
$ | (7 | ) | $ | 1 | $ | 2 | $ | 11 | ||||||||
|
Occupant Safety Systems
|
31 | 2 | 35 | 3 | |||||||||||||
|
Automotive Components
|
(1 | ) | 2 | 7 | 4 | ||||||||||||
|
Total restructuring charges
|
$ | 23 | $ | 5 | $ | 44 | $ | 18 | |||||||||
9
Severance and other charges
Three Months Ended
Nine Months Ended
September 30,
September 24,
September 30,
September 24,
2005
2004
2005
2004
(Dollars in millions)
$
$
1
$
11
$
11
31
2
33
2
1
2
9
4
$
32
$
5
$
53
$
17
| Restructuring reserves |
| Reclassifications | ||||||||||||||||||||||||
| and Effects of | ||||||||||||||||||||||||
| Current | Purchase | Used for | Foreign | |||||||||||||||||||||
| Beginning | Period | Price | Purposes | Currency | Ending | |||||||||||||||||||
| Balance | Accruals | Allocation | Intended | Translation | Balance | |||||||||||||||||||
| (Dollars in millions) | ||||||||||||||||||||||||
|
Three months ended September 30, 2005
|
$ | 36 | $ | 22 | $ | | $ | (36 | ) | $ | 12 | $ | 34 | |||||||||||
|
Nine months ended September 30, 2005
|
49 | 43 | | (64 | ) | 6 | 34 | |||||||||||||||||
|
Three months ended September 24, 2004
|
54 | 5 | | (13 | ) | | 46 | |||||||||||||||||
|
Nine months ended September 24, 2004
|
79 | 18 | 2 | (53 | ) | | 46 | |||||||||||||||||
| Curtailment gains |
10
| Asset impairments related to restructuring activities |
| Other asset impairments |
| 6. | Inventories |
| As of | |||||||||
| September 30, | December 31, | ||||||||
| 2005 | 2004 | ||||||||
| (Dollars in millions) | |||||||||
|
Finished products and work in process
|
$ | 340 | $ | 373 | |||||
|
Raw materials and supplies
|
316 | 311 | |||||||
|
Total inventories
|
$ | 656 | $ | 684 | |||||
| 7. | Goodwill and Intangible Assets |
| Goodwill |
11
Intangible assets
As of September 30, 2005
As of December 31, 2004
Gross
Net
Gross
Net
Carrying
Accumulated
Carrying
Carrying
Accumulated
Carrying
Amount
Amortization
Amount
Amount
Amortization
Amount
(Dollars in millions)
$
452
$
(58
)
$
394
$
452
$
(42
)
$
410
80
(26
)
54
81
(18
)
63
532
(84
)
448
533
(60
)
473
292
292
292
292
$
824
$
(84
)
$
740
$
825
$
(60
)
$
765
| 8. | Other (Income) Expense Net |
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | ||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
| (Dollars in millions) | |||||||||||||||||
|
Minority interest
|
$ | 1 | $ | 3 | $ | 5 | $ | 10 | |||||||||
|
Earnings of affiliates
|
(2 | ) | (3 | ) | (12 | ) | (11 | ) | |||||||||
|
Foreign currency exchange (gains) losses
|
4 | 3 | 23 | 3 | |||||||||||||
|
Provision for bad debts
|
2 | 7 | 17 | 7 | |||||||||||||
|
Miscellaneous other income
|
(6 | ) | (3 | ) | (22 | ) | (18 | ) | |||||||||
|
Other (income) expense net
|
$ | (1 | ) | $ | 7 | $ | 11 | $ | (9 | ) | |||||||
| 9. | Accounts Receivable Securitization |
12
| 10. | Income Taxes |
13
| 11. | Pension Plans and Post-Retirement Benefits Other Than Pensions (OPEB) |
| Pension Plans |
| Three Months Ended | ||||||||||||||||||||||||
| September 30, 2005 | September 24, 2004 | |||||||||||||||||||||||
| Rest of | Rest of | |||||||||||||||||||||||
| U.S. | U.K. | World | U.S. | U.K. | World | |||||||||||||||||||
| (Dollars in millions) | ||||||||||||||||||||||||
|
Defined benefit plans
|
||||||||||||||||||||||||
|
Service cost
|
$ | 7 | $ | 9 | $ | 5 | $ | 8 | $ | 9 | $ | 6 | ||||||||||||
|
Interest cost on projected benefit obligations
|
17 | 62 | 8 | 17 | 61 | 8 | ||||||||||||||||||
|
Expected return on plan assets
|
(15 | ) | (84 | ) | (3 | ) | (13 | ) | (84 | ) | (3 | ) | ||||||||||||
|
Net pension cost (income)
|
$ | 9 | $ | (13 | ) | $ | 10 | $ | 12 | $ | (14 | ) | $ | 11 | ||||||||||
14
Nine Months Ended
September 30, 2005
September 24, 2004
Rest of
Rest of
U.S.
U.K.
World
U.S.
U.K.
World
(Dollars in millions)
$
21
$
27
$
15
$
24
$
25
$
16
51
192
24
51
169
22
(43
)
(260
)
(9
)
(39
)
(233
)
(9
)
$
29
$
(41
)
$
30
$
36
$
(39
)
$
29
| Post-Retirement Benefits Other Than Pensions (OPEB) |
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 24, | September 30, | September 24, | |||||||||||||
| 2005 | 2004 | 2005 | 2004 | |||||||||||||
| (Dollars in millions) | ||||||||||||||||
|
Service cost
|
$ | 2 | $ | 3 | $ | 6 | $ | 6 | ||||||||
|
Interest cost
|
12 | 14 | 36 | 46 | ||||||||||||
|
Settlement gain
|
| | (3 | ) | | |||||||||||
|
Amortization of unrecognized income
|
(2 | ) | | (6 | ) | | ||||||||||
|
Net post-retirement benefit cost
|
$ | 12 | $ | 17 | $ | 33 | $ | 52 | ||||||||
15
12.
Debt
As of
September 30,
December 31,
2005
2004
(Dollars in millions)
$
38
$
40
$
972
$
1,063
293
306
1,293
1,512
186
202
33
39
16
19
2,793
3,141
17
19
$
2,776
$
3,122
| Senior Notes and Senior Subordinated Notes |
| Credit Facilities |
16
17
| 13. | Capital Stock |
18
| 14. | Share-based Compensation |
| 2005 | 2004 | |||||||
|
Expected volatility
|
28.0% | 31.0% | ||||||
|
Dividend Yield
|
0.00% | 0.00% | ||||||
|
Expected option life
|
5.0 years | 6.0 years | ||||||
|
Risk-free rate
|
3.70% | 3.78% | ||||||
19
Weighted-
Weighted-
Average
Thousands
Average
Remaining
Aggregate
of
Exercise
Contractual
Intrinsic
Options
Price
Term
Value
(Dollars in millions)
9,534
$
16.05
938
19.82
(164
)
11.67
(110
)
16.69
10,198
16.46
7.6
$
131
3,280
16.29
7.5
$
43
| Thousands | Weighted- | |||||||
| of | Average | |||||||
| Restricted | Grant-Date | |||||||
| Nonvested Shares | Stock Units | Fair Value | ||||||
|
Nonvested at January 1, 2005
|
14 | $ | 19.73 | |||||
|
Granted
|
559 | 19.81 | ||||||
|
Vested
|
(4 | ) | 20.21 | |||||
|
Forfeited
|
(4 | ) | 19.82 | |||||
|
Nonvested at September 30, 2005
|
565 | 19.81 | ||||||
| 15. | Related Party Transactions |
20
21
16.
Operating Segments
Three Months Ended
Nine Months Ended
September 30,
September 24,
September 30,
September 24,
2005
2004
2005
2004
(Dollars in millions)
$
1,670
$
1,620
$
5,470
$
5,126
859
751
2,755
2,504
388
368
1,282
1,195
$
2,917
$
2,739
$
9,507
$
8,825
$
46
$
61
$
217
$
223
44
47
232
230
15
16
79
78
105
124
528
531
(31
)
(29
)
(101
)
(81
)
(59
)
(60
)
(173
)
(183
)
(7
)
(48
)
$
15
$
35
$
247
$
219
$
2
$
1
$
6
$
2
24
7
62
16
10
14
32
40
$
36
$
22
$
100
$
58
| 17. | Contingencies |
22
23
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
| Executive Overview |
| | a decline in market share for vehicle sales among some of our largest customers; | |
| | the deteriorating financial condition of certain of our customers and the resulting uncertainty as they undergo (or contemplate undergoing) restructuring initiatives, including in certain cases, reorganization under bankruptcy laws; | |
| | continuing pricing pressure from OEMs; | |
| | the continued rise in inflationary pressures impacting certain commodities such as resins, chemicals and yarns, despite declines in the cost of ferrous metals from recent all-time highs; | |
| | the growing concerns over the economic viability of our Tier 2 and Tier 3 supply base as they face inflationary pressures and financial instability in certain of their customers; | |
| | rising interest rates; | |
| | the continued strengthening of the U.S. dollar against various foreign currencies; and | |
| | reduced funding of research and development projects. |
24
25
| Results of Operations |
| Total Company Results of Operations |
| Three Months Ended | |||||||||
| September 30, | September 24, | ||||||||
| 2005 | 2004 | ||||||||
| (Dollars in millions) | |||||||||
|
Sales
|
$ | 2,917 | $ | 2,739 | |||||
|
Cost of sales
|
2,623 | 2,458 | |||||||
|
Gross profit
|
294 | 281 | |||||||
|
Administrative and selling expenses
|
135 | 130 | |||||||
|
Research and development expenses
|
43 | 36 | |||||||
|
Amortization of intangible assets
|
8 | 8 | |||||||
|
Restructuring charges and asset impairments
|
35 | 5 | |||||||
|
Other (income) expense net
|
(1 | ) | 7 | ||||||
|
Operating income
|
74 | 95 | |||||||
|
Interest expense net
|
59 | 59 | |||||||
|
Accounts receivable securitization costs
|
| 1 | |||||||
|
Earnings before income taxes
|
15 | 35 | |||||||
|
Income tax expense
|
5 | 22 | |||||||
|
Net earnings
|
$ | 10 | $ | 13 | |||||
| Three Months Ended September 30, 2005 Compared to Three Months Ended September 24, 2004 |
26
27
Nine Months Ended
September 30,
September 24,
2005
2004
(Dollars in millions)
$
9,507
$
8,825
8,443
7,840
1,064
985
397
386
149
115
24
25
56
18
11
(9
)
427
450
171
181
7
48
2
2
247
219
102
128
$
145
$
91
| Nine Months Ended September 30, 2005 Compared to Nine Months Ended September 24, 2004 |
28
| | $1 million related to the write-off of unamortized debt issuance costs in conjunction with the repayment of a portion of the then-existing term loan facilities in the second quarter of 2004; | |
| | $11 million write-off of unamortized debt issuance costs in conjunction with our January 2004 refinancing of the then-existing term loan facilities; and | |
| | $30 million of redemption fees and $6 million write-off of unamortized debt issuance costs associated with our dollar and euro-denominated senior notes and senior-subordinated notes which were partially redeemed in March 2004. |
29
| SEGMENT RESULTS OF OPERATIONS |
| Three Months Ended | Nine Months Ended | |||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | |||||||||||||||
| 2005 | 2004 | 2005 | 2004 | |||||||||||||||
| (Dollars in millions) | ||||||||||||||||||
|
Sales to external customers:
|
||||||||||||||||||
|
Chassis Systems
|
$ | 1,670 | $ | 1,620 | $ | 5,470 | $ | 5,126 | ||||||||||
|
Occupant Safety Systems
|
859 | 751 | 2,755 | 2,504 | ||||||||||||||
|
Automotive Components
|
388 | 368 | 1,282 | 1,195 | ||||||||||||||
|
Total sales
|
$ | 2,917 | $ | 2,739 | $ | 9,507 | $ | 8,825 | ||||||||||
|
Earnings before taxes:
|
||||||||||||||||||
|
Chassis Systems
|
$ | 46 | $ | 61 | $ | 217 | $ | 223 | ||||||||||
|
Occupant Safety Systems
|
44 | 47 | 232 | 230 | ||||||||||||||
|
Automotive Components
|
15 | 16 | 79 | 78 | ||||||||||||||
|
Segment earnings before taxes
|
105 | 124 | 528 | 531 | ||||||||||||||
|
Corporate expense and other
|
(31 | ) | (29 | ) | (101 | ) | (81 | ) | ||||||||||
|
Financing costs
|
(59 | ) | (60 | ) | (173 | ) | (183 | ) | ||||||||||
|
Loss on retirement of debt
|
| | (7 | ) | (48 | ) | ||||||||||||
|
Earnings before taxes
|
$ | 15 | $ | 35 | $ | 247 | $ | 219 | ||||||||||
| Chassis Systems |
| Three Months Ended September 30, 2005 Compared to Three Months Ended September 24, 2004 |
| Three Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 1,670 | $ | 1,620 | ||||
|
Earnings before taxes
|
46 | 61 | ||||||
|
Curtailment gains
|
7 | | ||||||
|
Severance and other restructuring charges
|
| (1 | ) | |||||
30
| Nine Months Ended September 30, 2005 Compared to Nine Months Ended September 24, 2004 |
| Nine Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 5,470 | $ | 5,126 | ||||
|
Earnings before taxes
|
217 | 223 | ||||||
|
Restructuring charges and asset impairments
|
(2 | ) | (11 | ) | ||||
| Occupant Safety Systems |
| Three Months Ended September 30, 2005 Compared to Three Months Ended September 24, 2004 |
| Three Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 859 | $ | 751 | ||||
|
Earnings before taxes
|
44 | 47 | ||||||
|
Restructuring charges and asset impairments
|
(32 | ) | (2 | ) | ||||
31
| Nine Months Ended September 30, 2005 Compared to Nine Months Ended September 24, 2004 |
| Nine Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 2,755 | $ | 2,504 | ||||
|
Earnings before taxes
|
232 | 230 | ||||||
|
Restructuring charges and asset impairments
|
(36 | ) | (3 | ) | ||||
| Automotive Components |
| Three Months Ended September 30, 2005 Compared to Three Months Ended September 24, 2004 |
| Three Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 388 | $ | 368 | ||||
|
Earnings before taxes
|
15 | 16 | ||||||
|
Restructuring charges and asset impairments
|
(10 | ) | (2 | ) | ||||
32
| Nine Months Ended September 30, 2005 Compared to Nine Months Ended September 24, 2004 |
| Nine Months Ended | ||||||||
| September 30, | September 24, | |||||||
| 2005 | 2004 | |||||||
| (Dollars in millions) | ||||||||
|
Sales
|
$ | 1,282 | $ | 1,195 | ||||
|
Earnings before taxes
|
79 | 78 | ||||||
|
Restructuring charges and asset impairments
|
(18 | ) | (4 | ) | ||||
33
34
35
36
| Three Months Ended | Nine Months Ended | ||||||||||||||||
| September 30, | September 24, | September 30, | September 24, | ||||||||||||||
| 2005 | 2004 | 2005 | 2004 | ||||||||||||||
| (Dollars in millions) | |||||||||||||||||
|
Research and development expenses
|
$ | 43 | $ | 36 | $ | 149 | $ | 115 | |||||||||
|
Engineering costs
|
157 | 118 | 448 | 354 | |||||||||||||
|
Total
|
$ | 200 | $ | 154 | $ | 597 | $ | 469 | |||||||||
37
38
39
40
| Item 3. | Quantitative and Qualitative Disclosures About Market Risks |
41
| Assuming a 10% | Assuming a 10% | Favorable | |||||||||||
| increase in | decrease in | (unfavorable) | |||||||||||
| Market Risk | prices/rates | prices/rates | change in | ||||||||||
| (Dollars in millions) | |||||||||||||
|
Foreign Currency Rate Sensitive:
|
|||||||||||||
|
Forwards *
|
|||||||||||||
|
Long US$
|
$ | (58 | ) | $ | 63 | Fair value | |||||||
|
Short US$
|
$ | 18 | $ | (19 | ) | Fair value | |||||||
|
Debt
|
|||||||||||||
|
Foreign currency denominated
|
$ | (53 | ) | $ | 53 | Fair value | |||||||
|
Interest Rate Sensitive:
|
|||||||||||||
|
Debt
|
|||||||||||||
|
Fixed rate
|
$ | 25 | $ | (26 | ) | Fair value | |||||||
|
Variable rate
|
$ | (9 | ) | $ | 9 | Cash flow | |||||||
|
Swaps
|
|||||||||||||
|
Pay variable/ receive fixed
|
$ | (1 | ) | $ | 1 | Fair value | |||||||
| * | Includes only the risk related to the derivative instruments that serve as hedges and does not include the related underlying hedged item or any other operating transactions. The analyses also do not factor in a potential change in the level of variable rate borrowings or derivative instruments outstanding that could take place if these hypothetical conditions prevailed. |
| Item 4. | Controls and Procedures |
| Item 1. | Legal Proceedings |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
| (c) | Issuer repurchases |
42
| Item 5. | Other Information |
43
| Item 6. | Exhibits |
| Exhibit | ||||||
| Number | Exhibit Name | |||||
| 2.1 | Agreement for the Purchase and Sale of Shares By and Among TRW Automotive Inc, Automotive Holdings (Spain) SL and Ms. Nuria Castellón García, Mr. Luis Gras Tous, Ms. Maria Luisa Gras Castellón and Mr. José Ramón Sanz Pinedo, dated September 6, 2005. | |||||
| 2.2 | Schedule 8.1, Representations and Warranties of the Sellers, to the Agreement for the Purchase and Sale of Shares By and Among TRW Automotive Inc, Automotive Holdings (Spain) SL and Ms. Nuria Castellón García, Mr. Luis Gras Tous, Ms. Maria Luisa Gras Castellón and Mr. José Ramón Sanz Pinedo, dated September 6, 2005. | |||||
| 31(a) | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to §302 of the Sarbanes-Oxley Act of 2002. | |||||
| 31(b) | Certification Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to §302 of theSarbanes-Oxley Act of 2002. | |||||
| 32(a) | Certification Pursuant to 18 U.S.C. §1350, As Adopted Pursuant to §906 of the Sarbanes-Oxley Act of 2002. | |||||
| 32(b) | Certification Pursuant to 18 U.S.C. §1350, As Adopted Pursuant to §906 of the Sarbanes-Oxley Act of 2002. | |||||
44
45
TRW Automotive Holdings Corp.
(Registrant)
By:
/s/ JOSEPH S. CANTIE
Joseph S. Cantie
Executive Vice President and Chief Financial Officer
(On behalf of the Registrant and as Principal Financial Officer)
Exhibit
Number
Exhibit Name
2
.1
Agreement for the Purchase and Sale of Shares By and Among TRW
Automotive Inc, Automotive Holdings (Spain) SL and
Ms. Nuria Castellón García, Mr. Luis Gras
Tous, Ms. Maria Luisa Gras Castellón and
Mr. José Ramón Sanz Pinedo, dated
September 6, 2005.
2
.2
Schedule 8.1, Representations and Warranties of the Sellers, to
the Agreement for the Purchase and Sale of Shares By and Among
TRW Automotive Inc, Automotive Holdings (Spain) SL and
Ms. Nuria Castellón García, Mr. Luis Gras
Tous, Ms. Maria Luisa Gras Castellón and
Mr. José Ramón Sanz Pinedo, dated
September 6, 2005.
31(a)
Certification Pursuant to Rule 13a-14(a) under the
Securities Exchange Act of 1934, as adopted pursuant to
§302 of the Sarbanes-Oxley Act of 2002.
31(b)
Certification Pursuant to Rule 13a-14(a) under the
Securities Exchange Act of 1934, as adopted pursuant to
§302 of the Sarbanes-Oxley Act of 2002.
32(a)
Certification Pursuant to 18 U.S.C. §1350, As Adopted
Pursuant to §906 of the Sarbanes-Oxley Act of 2002.
32(b)
Certification Pursuant to 18 U.S.C. §1350, As Adopted
Pursuant to §906 of the Sarbanes-Oxley Act of 2002.
1
|
Parties
|
3 | |||
|
|
||||
|
Recitals
|
4 | |||
|
|
||||
|
Clauses
|
6 | |||
|
|
||||
|
1. Definitions
|
6 | |||
|
1. Purchase and Sale
|
6 | |||
|
2. Access to the Business and Activities of the DME Group
|
7 | |||
|
3. Purchase Price
|
7 | |||
|
4. Conditions Precedent
|
10 | |||
|
5. Closing
|
11 | |||
|
6. Sellers Obligations During the Interim Period
|
13 | |||
|
8. Representations and Warranties of the Sellers
|
17 | |||
|
9. Representations and Warranties of the Purchaser
|
18 | |||
|
10. Obligation to Indemnify by the Seller
|
18 | |||
|
11. Time
Limits Limitation of Liabilities
|
20 | |||
|
12. Claims Procedure for Indemnity of Losses
|
21 | |||
|
13. Sellers Non-Competition
|
24 | |||
|
14. Confidentiality
|
24 | |||
|
15. Actions After Closing
|
25 | |||
|
16. Bank Guarantees
|
25 | |||
|
17. Miscellaneous
|
26 | |||
|
18. Governing Law & Jurisdiction
|
29 | |||
|
19. Language
|
29 | |||
|
|
||||
|
LIST OF SCHEDULES
|
31 | |||
|
|
||||
|
DEFINITIONS
|
32 |
2
| (1) | Ms. Nuria Castellón García of legal age, with domicile in Madrid, Ronda de Sobradiel, 3, and Identification Number 01456600-X. | |
| (2) | Mr. Luis Gras Tous of legal age, with domicile in Madrid, Ronda de Sobradiel, 3, and Identification Number 36215351-B; | |
| (3) | Ms. María Luisa Gras Castellón of legal age, with domicile Madrid, C/ Piquer, 2, and Identification Number 2183747-N.; and | |
| (4) | Mr. José Ramón Sanz Pinedo of legal age, with domicile in Madrid, C/ Piquer, 2, and Identification Number 51589424-X; | |
| Hereinafter all of them to be collectively referred to as the Sellers and individually and indistinctly as a Seller. |
| (5) | TRW Automotive Inc, a company incorporated and organized under the laws of Delaware, USA, whose registered office is 12001 Tech Center Drive, Livonia, Michigan, USA, and Automotive Holdings (Spain), S.L., a company duly organised and incorporated under the laws of Spain, with principal office at Polígono Industrial Landaben C/D, s/n, 31012, Pamplona (Spain) and holder of Tax Identification Number B-1774094 (hereinafter jointly called, TRW or the Purchaser), respectively represented by Mr. Guenter Brenner, of legal age, German nationality, bearer of Passport number 6386502642, in force, and Mr. Roderick McLaren, of legal age, British nationality, bearer of Passport number 702200257, in force. | |
| Hereinafter the Sellers and the Purchaser to be collectively referred to as the Parties. |
3
| I. | Whereas the Sellers are the direct holders of the ownership interests in the following companies, as detailed in Schedule I: |
| a) | Dalphi Metal España, S.A., (DME) representing 68,3994% of the share capital of such company (the DME Shares); | ||
| b) | Dalphi Metal Seguridad, S.A., (DMS) representing 2% of the share capital of such company (the DMS Shares) | ||
| c) | Dalphi Metal Internacional, S.A., (DMI) representing 2% of the share capital of such company (the DMI Shares). | ||
| d) | Dalphi Metal Portugal, S.A., (DMP) representing 2% of the share capital of such company (the DMP Shares), | ||
| e) | Safe Life Industria de Componentes de Segurança Automovel, S.A (SL) representing 0.0004% of the share capital of such company, | ||
| f) | Safe Bag Industria Componentes Segurança Automovel, S.A (SB), representing 0.05% of the share capital of such company, | ||
| g) | Dalphi Metal Tunisie, S.A.R.L. (DMT) representing 0.0083% of the share capital of such company, | ||
| h) | Dalphi Metal Brasil, L.T.D.A. (DMB) representing 1% of the share capital of such company, | ||
| i) | Spria S.A., one share, representing 0.00005% of the share capital of such company |
| II. | Whereas DME together with the Sellers controls the voting rights set out next to each of the Companies listed below, in which DME is the direct or indirect holder of the following ownership interests as indicated below, as detailed in Schedule II: |
| a) | Dalphi Metal Adriaticus (100%) | ||
| b) | Dalphi Metal Ltd. (100%) | ||
| c) | Dalphi Metal Italia, S.R.L. (100%) | ||
| d) | Dalphi Metal France, S.A.R.L. (100%) |
4
| e) | Safe Life Industria de Componentes de Segurança Automovel, S.A. (100%) | ||
| f) | Dalphi Metal Tunisie, S.A.R.L. (100%) | ||
| g) | Safe Bag Industria Componentes Segurança Automovel, S.A. (100%) | ||
| h) | Dalphi Metal Brasil, L.T.D.A. (100%) | ||
| i) | Spria, S.A. (49,99%) | ||
| j) | Dalphi Metal Seguridad, S.A. (51%) | ||
| k) | Dalphi Metal Internacional, S.A. (51%) | ||
| l) | Dalphi Metal Portugal, S.A. (51%) | ||
| m) | Mediterránea de Volants, S.L. (49%) | ||
| n) | Pimsa Direksiyon Sanayi ve Ticaret, A.S. (26,5000%) | ||
| o) | Garevol, S.L. (25%) | ||
| p) | Céltica de Componentes del Automóvil, S.L. (25%) | ||
| q) | Nihon Plast Co. Ltd (approximately 10.39% following the capital increase announced on July 29 th, 2005. The ownership interest currently represents 13.09%) | ||
| r) | CTAG (7.3150%) |
| III. | Whereas for the purposes of further reference in this Agreement, all the companies of Recitals I and II shall collectively referred to as the DME Portfolio, and shall be classified as follows: |
| (i) | Dalphi Metal Adriaticus, Dalphi Metal Ltd., Dalphi Metal Italia S.R.L., Dalphi Metal France, S.R.A.L., Safe Life Industria de Componentes de Segurança Automóvel, S.A., Dalphi Metal Tunisie, S.A.R.L., Safe Bag Industria Componentes Segurança Automovel, S.A., Dalphi Metal Brasil, L.T.D.A. and Spria S.A. will be collectively referred to as the Controlled Subsidiaries; | ||
| (ii) | Dalphi Metal Seguridad, S.A., Dalphi Metal Internacional, S.A. and Dalphi Metal Portugal, S.A. shall be collectively referred to as the Relevant Companies; DME, Controlled Subsidiaries and Relevant Companies together will also be referred to as the DME Group and |
5
| (iii) | All other equity interests not listed under Clauses (i) and (ii) above shall be collectively referred to as the Other Participations. |
| IV. | Whereas the principal activities of the DME Group mainly consist of the design, development, production, commercialization, sale and distribution of automotive safety systems, including in particular steering wheels, bags, airbag inflators and modules (the Activities of the DME Group). | |
| V. | Whereas the Parties recognize and acknowledge the rights under the laws of Spain, France and Portugal of minority shareholders in the DME Group, and TRW will extend the offer to acquire the shares of the minority holders, subject however to successful negotiations on terms and conditions, appropriate agreements and taking into account the particular circumstances of the minority holders. | |
| VI. | Whereas pursuant to the Letter of Intent dated May 10, 2005 among the Parties, TRW and its representatives have conducted certain limited due diligence reviews. | |
| VII. | Whereas the Parties believe the Transaction is in the best interests of the DME Group, its customers, employees and shareholders. |
| 1. | Definitions | |
| 1.1 | For purposes of this Agreement, the terms appearing in Schedule 1.1 , shall have the meaning set forth therein. | |
|
|
||
| 2. | Purchase and Sale | |
| 2.1 | The Sellers hereby agree to sell, and Purchaser hereby agrees to buy, full title to the Shares identified in Schedule 2.1 for the Purchase Price and subject to the conditions set out in this Agreement. | |
| 2.2 | The Shares shall be sold and transferred free of liens, options, encumbrances, claims or any other seizure rights or Personal Rights ( Derechos Personales ) in |
6
| favor of third parties and shall be sold and transferred with all economic, voting and other rights that are inherent thereto. | ||
| 2.3 | The Parties hereby agree that on Closing, at TRWs option, the effective acquisition of the Shares could be implemented totally by any one of the companies identified as Purchaser, or partially by both of them in the proportion TRW deems appropriate on Closing. In all events TRW Automotive Inc. and Automotive Holdings (Spain) S.L. assume jointly and severally ( solidariamente ) all obligations undertaken by Purchaser under this Agreement. | |
| 2.4 | Completion of the Transaction is subject to the satisfaction of the Conditions Precedent. | |
|
|
||
| 3. | Access to the business and Activities of the DME Group | |
| 3.1 | Subject to the terms and conditions of this Agreement, the Purchaser acquires from the Sellers the Shares. By acquiring the Shares, the Purchaser is acquiring control over the business activity of DME and over its assets and rights. Furthermore, the Purchaser acquires indirect control over the business activities of the Controlled Subsidiaries and the Relevant Companies and over their respective assets and rights. | |
| 3.2 | The transfer of title and access to control described in the preceding paragraph constitute the cause and final purpose of this purchase and sale transaction. | |
|
|
||
| 4. | Purchase Price | |
| 4.1 | The Purchase Price for the Shares shall be 112,500,000.00 (in words: Euros one hundred and twelve million and five hundred thousand) plus or minus (as the case may be) the amount of the Adjustment, if any. | |
| 4.2 | On the Closing Date, the Purchaser shall deposit 6,000,000 of the Purchase Price (in words Six Million Euros) into an interest bearing escrow account with an escrow agent reasonably satisfactory to the Parties (the Escrow Fund) pursuant to the instructions to the escrow agent as set out in Schedule 4.2 . On the Closing Date the balance of the Purchase Price (i.e. 106,500,000.00) shall be paid to the Sellers in the following manner: |
| (a) | By collective nominative bank draft of 39,000,000.00; and |
7
| (b) | By individual bank checks and in the respective amounts expressly stated in Schedule 4.2 (b) . |
| 4.3 | Post closing Adjustments: |
| a) | Closing Audit : Promptly after the Closing Date, the Purchaser will cause either ERNST & YOUNG, S.L. or KPMG AUDITORES, S.L., at Purchasers sole option, (the Auditors), independent certified public accountants, to conduct an audit of the Closing Financial Statements including the individual and consolidated DME Group balance sheet as of Closing Date (the Closing Balance Sheet). Within ninety (90) days after the Closing Date or as soon thereafter as reasonably possible, the Auditors will deliver to the Sellers and the Purchaser a report (the Auditors Report) based on the audit stating the net book value of assets included in the Closing Balance Sheet (the Closing Assets) and the book amount of liabilities included in the Closing Balance Sheet (the Closing Liabilities), as the same were (or should have been) reflected on the books of the DME Group as of the Closing Date in accordance with the accounting principles described in clause 4.3(c) hereof. | ||
| b) | Review by Sellers : Following receipt of the Auditors Report, Sellers will be afforded a period of thirty (30) days to review the Closing Balance Sheet, audit working papers, and the Auditors Report on the Closing Financial Statements. At or before the end of that period, Sellers will either (i) accept the Auditors Report in its entirety, in which case the Closing Assets and the Closing Liabilities will be deemed to be as set forth on the Auditors Report, or (ii) deliver to the Purchaser and the Auditors written notice and a detailed written explanation of those items in the Auditors Report or Closing Balance Sheet which Sellers dispute, in which case the net book value of the Closing Assets and the book amount of the Closing Liabilities not affected by the disputed items will be deemed to be as set forth on the Auditors Report and the items identified by Sellers shall be deemed to be in dispute. Within a further period of thirty (30) days from the end of the aforementioned review period, the Parties will attempt to resolve in good faith any disputed items. Failing such resolution, the unresolved disputed items will be referred for final binding resolution to a second internationally-recognized firm of certified public accountants mutually acceptable to the Purchaser and Sellers. The identity of this second accountant shall be immediately notified by both Parties to the Escrow Agent upon appointment. The net book value of Closing Assets and book amount of Closing Liabilities affected by such unresolved disputed items (if any) will be deemed to be as determined by such second firm in accordance with the accounting |
8
| principles described in this clause 4.3(c) within thirty (30) days of such reference. The decision of such second firm will not be appealable by the Purchaser or Sellers. The fees of the second firm of certified public accountants will be shared equally between Purchaser and Sellers. | |||
| c) | Accounting Principles : The net book value of the Closing Assets and the book amount of the Closing Liabilities will be determined in accordance with Spanish generally accepted accounting principles as properly and consistently applied by the DME Group in the past except that, for purposes of the Adjustment, (i) the assets and liabilities of Spria, S.A. will be fully consolidated in the Closing Balance Sheet as well as from the calculation of the Base-Line Net Book Value (as defined below) and both shall be pro-forma for DMEs ownership of 100% of Sprias share capital; (ii) the value of the interest in Nihon Plast Co. Ltd will be excluded from the calculation of both the Base-Line Net Book Value and the Closing Net Book Value; (iii) the Closing Net Book Value and the Base-Line Net Book Value will be pro-forma for DMEs ownership of 51% of the share capital of DMI, DMS and DMP; and (iv) there will be no increase in provisions for environmental matters beyond those previously in existence, those arising from matters occurring after December 31, 2004 and those agreed to by Sellers and Purchaser as a result of Purchasers due diligence. Only assets and liabilities reflected on the consolidated balance sheet of the DME Group (or which should have been) in accordance with the aforementioned accounting principles will be taken into account for purposes of determining the Closing Net Book Value. | ||
| d) | Base-Line Net Book Value : The Base-Line Net Book Value will be an amount equal to 86,157,000.00(in words: eighty six million one hundred and fifty-seven thousand euros), pursuant to the calculation provided in Schedule 4.3 d) . | ||
| e) | Determination of Closing Net Book Value : The Closing Net Book Value will be an amount equal to the net book value of assets included in the Closing Assets minus the book amount of liabilities included in the Closing Liabilities as of the Closing Date, both as determined under clauses 4.3(a) and (b) hereof. | ||
| f) | Amount of Adjustment : If the Closing Net Book Value is equal to the Base-Line Net Book Value, then the Adjustment will equal zero. If the Closing Net Book Value is more than the Base-Line Net Book Value, then the Adjustment will be a positive amount equal to [68.3994%] of the amount by which the Closing Net Book Value is more than the Base-Line Net Book |
9
| Value. If the Closing Net Book Value is less than the Base-Line Net Book Value, then the Adjustment will be a negative amount equal to [68.3994%] of the amount by which the Closing Net Book Value is less than the Base-Line Net Book Value, provided however that such negative Adjustment will never exceed the amount of 6,000,000.00. | |||
| g) | Payment of Adjustment : If the Adjustment is a positive amount, then the Purchaser will pay Sellers the amount of the Adjustment and the escrow agent will release to Sellers the Escrow Fund, within ten (10) business days after the final determination of the amount of the Adjustment pursuant to clause 4.3(f) hereof. If the Adjustment is a negative amount, then the escrow agent will release (i) to Purchaser, the amount of the Adjustment and (ii) to Sellers, any balance of the Escrow Fund after deducting the Adjustment. | ||
| h) | Without prejudice to the Adjustment as indicated above, the Purchase Price, and therefore the payment of the 106,500,000 to be delivered on Closing to the Sellers, will be reduced in the amounts paid to the Sellers by the corresponding DME Group companies in consideration for the effective transfer of the minority interest stakes pursuant to Schedule 7.2 |
| 5. | Conditions Precedent | |
| 5.1 | The completion of the Transaction is subject to the satisfaction of each and every one of the following conditions precedent: |
| a) | The European Commission shall have issued a decision that the concentration is compatible with the common market under the Merger regulations of the European Union (or having been deemed to have done so) and, in the event of a referral of the proposed transaction to a competent authority of a European State, no such state shall have restrained or prohibited the consummation of the Transaction. | ||
| b) | The absence of any Material Adverse Change between Signing and Closing. | ||
| c) | The Representations and Warranties of Sellers contained in this Agreement shall be true, accurate, and complete in all material respects as of the date hereof and as of the Closing Date (as if such Representations and Warranties had been made anew as of the Closing Date), in accordance with Schedule 6.4 f). | ||
| d) | The Sellers shall have provided a First Demand Bank Guarantee in accordance with clause 16.1 of this Agreement. |
10
| 5.2 | Each of the Parties undertakes to use its best efforts to carry out the actions and process the documents necessary to obtain the aforementioned authorizations, consents, verifications and agreements reasonably in advance. | |
| 5.3 | Should all the conditions precedent referred to in Clause 5.1 not be fulfilled by March 31, 2006, and should the Purchaser not have waived those conditions pending fulfillment or the Parties having set a new date therefor, this Agreement shall be rendered without any effect whatsoever, except for the provisions referring to confidentiality under this Agreement, without any of the Parties having any claim against the other as a consequence thereof, except in the event of a breach of its obligations under Clause 5.2. | |
|
|
||
| 6. | Closing | |
| 6.1 | The Closing Date shall take place the last Business Day of the month in which the Condition Precedent set out in Clause 5.1.a) shall have been fulfilled and notified to the Purchaser or have been deemed to have occurred, provided however that if such notice has been served (or deemed to have been done) less than 10 calendar days prior to the end of such month, Closing Date shall occur on the last Business Day of the following month. Purchaser undertakes to inform Sellers within 3 Business Days of having received notification of the European Commission decision. | |
| 6.2 | On the Closing Date, the Parties shall execute the transfer of title to the Shares before a notary public by the delivery of the Shares and their endorsement and complete the other actions set out in clause 6.4. | |
| 6.3 | The Closing shall take place in Madrid, at [12:00 pm] at the offices of the Notary Public [Mr. Carlos de Prada Guaita] or any other notary or location mutually agreed by the Parties. | |
| 6.4 | On the Closing Date: |
| a) | The Purchaser or the Sellers shall deliver a copy of the document evidencing the satisfaction of the Condition Precedent set out in Clause 5.1 a). | ||
| b) | The Parties shall exhibit powers of attorney sufficient for the execution of the Transaction and the other transactions contemplated by this Agreement and |
11
| state before the Notary the satisfactory completion of Conditions Precedent set out in Clause 5.1. | |||
| c) | The Sellers shall deliver certificates evidencing their compliance with the requirements of Clause 7.1, the completion of the matters covered by Clause 7.2 and the absence of any Material Adverse Change, in accordance with the form set forth in Schedule 6.4 c) . | ||
| d) | The Sellers shall deliver a certificate issued by the management body of each of the companies in which shares are being transferred evidencing the completion of the requirements set out in the Articles of Association for the transfer of the shares in accordance with the terms set forth in Schedule 6.4 d) . | ||
| e) | The Sellers shall deliver to the Purchaser a certificate evidencing the continued validity and effectiveness of the Representations and Warranties on the Closing Date, in accordance with the terms of Schedule 6.4 e) . | ||
| f) | The Sellers shall deliver to the Purchaser an irrevocable first demand bank guarantee ( Aval a primer requerimiento ) in the amount of 39,000,000 (in words: Thirty-nine million Euros) in accordance with clause 16.1 of the Agreement. | ||
| g) | The Sellers shall deliver to the Purchaser the certificates of title representing the Shares duly endorsed in favor of the Purchaser and shall deliver to the Notary Public all the public deeds or documents that justify ownership of the Shares for due recording of the transfer on such original titles of ownership. | ||
| h) | The Purchaser shall pay to the Sellers and deliver to the escrow agent the Purchase Price in the manner provided for in Clause 4.2. | ||
| i) | Sellers shall have performed and complied with all agreements and conditions required by this Agreement to be performed or satisfied by Sellers, and Sellers shall deliver to Purchaser all documents, certificates, and instruments required to be delivered by Sellers under the terms of this Agreement. | ||
| j) | Sellers shall have delivered to the Purchaser the letter related to the lease agreements set out in accordance with Schedule 6.4.j) |
| 6.5 | All of the actions described in this clause 6 shall be undertaken simultaneously as a single transaction ( unidad de acto ). Consequently, none of the foregoing actions shall be held to have been completed until such time as each and every one of the other actions is completed. |
12
| 7. | Sellers Obligations During the Interim Period | |
| 7.1 | During the Interim Period, the Sellers shall act, and cause DME, the Controlled Subsidiaries, the Relevant Companies and where applicable and to the extent possible, given the rights of Directors and/or shareholders or pursuant to contract, the Other Participations, to act with the greatest diligence to: |
| a) | Avoid any act or omission which could cause a Material Adverse Change to any of the DME Portfolio; | ||
| b) | Maintain the current organizational structure, management team, Personnel, and network of agents of the DME Portfolio, as well as the commercial relations with suppliers, customers, creditors, agents, lessors of real estate leased by such companies, and any third parties with which such companies maintain relations; | ||
| c) | Conduct the operations of the DME Portfolio in the Ordinary Course of Business, consistent with past practice as to nature, scope and manner of carrying on the business, taking into special consideration the signing of this Agreement and the protection, to the greatest extent possible, of all of the rights thereby acquired, or intended to be acquired by the Purchaser; | ||
| d) | Direct and manage the DME Portfolio in such a manner as to maintain the full truthfulness, accuracy, and completeness of the terms of the Representations and Warranties on the Closing Date; | ||
| e) | Inform and submit for the prior written approval of the Purchaser such actions, facts or omissions which arise outside the Ordinary Course of Business and specifically shall not, without the previous written consent from the Purchaser, which consent shall not be unreasonably withheld and which consent shall be deemed to have been given fifteen (15) calendar days after receipt by the Purchaser of the written request for approval unless Purchaser notifies Sellers otherwise: |
| (i) | Assume any obligation or responsibility except for those that arise in the Ordinary Course of Business and on an arms length basis; | ||
| (ii) | Issue, or adopt any resolution to issue shares, obligations, bonds, options, warrants or other securities or financial instruments of an analogous nature; |
13
| (iii) | Assume effective or contingent obligations or responsibilities (including, but not limited to, financial leasing or unregistered transactions) outside the Ordinary Course of Business and not under normal market terms and conditions or enter into any unusual, abnormal or onerous contract or commitment. | ||
| (iv) | A) Declare, agree or distribute final or interim dividends or other distributions from any of the DME Portfolios reserves or funds or make other payments in favor of the Sellers, previous shareholders or members of the board other than for the transfer of DMS, DMP and DMI shares and all other minority interest stakes, all of it pursuant to Schedule 7.2 and pay-roll; or B) cause or permit any of the DME Portfolio to acquire its own shares or redeem or reclassify its shares, increase or reduce its share capital. | ||
| (v) | Sell, assign, lease or in any other way transfer or subject to liens and encumbrances, any of its tangible or intangible assets or shares owned by the DME Group in the DME Portfolio. | ||
| (vi) | Grant guarantees or modify the provisions of already existing guarantees, lend money or advance payments to third parties, including the Sellers (except to the extent required in the Ordinary Course of Business and consistent with past practices for operation of the current DME Group cash management system), or execute any additional loan or credit facility agreements, or modify the provisions of already existing loans or credit facility agreements. | ||
| (vii) | Cancel credits, or waive any right to claim from third parties. | ||
| (viii) | Modify the articles of association of any DME Portfolio except as may be specifically required by law. | ||
| (ix) | Increase the remuneration of or establish additional consideration of any kind payable to directors, executives or employees of any of the DME Portfolio, or otherwise enter into or alter any employment, consulting or managerial services agreements relating to the DME Portfolio in excess of amounts required by a legally binding contract entered into prior to Signing and disclosed to Purchaser in due diligence. | ||
| (x) | Breach, cancel or amend any of the contracts, agreements or insurance policies that are binding on any of the DME Portfolio. |
14
| (xi) | Commit to make, or to make any capital expenditures per project in excess of 500,000.00 (in words: Euros five hundred thousand), or increase any previous commitment for capital expenditures in excess of such amount. | ||
| (xii) | Change or enter into collective bargaining agreements or other collective labor contracts. | ||
| (xiii) | Enter into any lease of real or personal property or any renewals thereof involving a term of more than one (1) year or rental obligation exceeding 50,000.00 Euros (in words: Euros fifty thousand) per annum in any single case. | ||
| (xiv) | Commence, enter into, or alter any pension, retirement, profit-sharing, employee stock option or stock purchase, bonus, deferred compensation, incentive compensation, life insurance, health insurance, fringe benefit, or other employee benefit plan or arrangement affecting employees of the DME Portfolio. | ||
| (xv) | Accelerate or delay the manufacture, sale or shipment of products of the DME Portfolio other than pursuant to specific requests initiated by customers. | ||
| (xvi) | Make or change any Taxes or taxes accounting method, settle any tax audit or proceeding, or file any amended tax returns, except in the Ordinary Course of Business consistent with past practice. |
| f) | Without prejudice to the provision in section (e) above, and provided that Sellers notify in English any urgent request to TRW Automotive GmbH, Industrie Strasse 20, 73551, Alfdorf, Germany, to the attention of Mr. Günter Brenner, Mr. Rod McLaren or Mr. Josef Hermes, Purchaser will undertake its best efforts to respond to Sellers within five (5) Business days after receipt of such urgent request for approval. | ||
| g) | Subject to, and in compliance with, applicable antitrust regulation, requirements and limitations and so long as it does not unreasonably interfere with the ordinary conduct of business, Sellers shall permit the Purchaser as broad as possible access to the Personnel, real estate, installations, contracts, books and registries and any other additional information of a financial, operational or analogous nature, or any other relevant information for the DME Portfolio which the Purchaser could reasonably request. |
15
| 7.2 | During the Interim Period the Sellers shall act, and cause DME, the DME Controlled Subsidiaries, the Relevant Companies and, where applicable and to the extent possible, given the rights of Directors and shareholders or pursuant to contract, the Other Participations, to complete the actions set forth in Schedule 7.2 . | |
| 7.3 | Material breach by the Sellers of the terms provided for in the preceding paragraphs of this clause shall give the Purchaser the option to demand specific performance of the Agreement or to terminate this Agreement pursuant to article 1124 of the Civil Code, without prejudice to any other remedies that Purchaser may be entitled for such breach. | |
| 7.4 | The same optional right to demand performance or to terminate this Agreement shall be granted to the Purchaser should any Material Adverse Change occur. If Purchaser elects to demand performance, the amount of the Loss resulting from the Material Adverse Change shall be deducted from the Purchase Price as an adjustment subject to Clause 4.3 and shall not prejudice or reduce Sellers liability under the Agreement for breaches of the Representations and Warranties or the First Demand Bank Guaranty securing such liability. | |
| 7.5 | Sellers may claim, as full and complete liquidated damages for breach of Purchasers obligations under this Agreement, the full amount of 10,000,000 in the Purchasers Bank Guarantee (as defined in Clause 16.2) provided that a court of competent jurisdiction determines in a firm and final judgment either: |
| (i) | A) each of the conditions precedent set forth in Clause 5.1 has been satisfied, B) the Sellers complied with all of their obligations under the Agreement and C) Purchasers failure to complete the Transaction was a breach of this Agreement; or | ||
| (ii) | That the Condition Precedent set out in Clause 5.1 (a) has not been fulfilled due to a breach of Purchasers obligations under Clause 7.6 of this Agreement. |
| In such events, Purchaser will have no further obligations or liabilities to Sellers of any type in respect of breach of this Agreement. |
16
| 7.6 | Notification to the Antitrust Authorities | |
| Purchaser will notify this Agreement to the competent antitrust authorities in all jurisdictions where it is required to do so promptly after signing. The Parties shall fully cooperate and be jointly responsible for the conduct of the proceedings before the antitrust authorities and shall cooperate fully and promptly to gather information. The Parties shall each provide to such authorities all information and materials reasonably requested in connection with such proceedings. Other than such antitrust notification, neither Purchaser nor Sellers have any knowledge that any other government or regulatory filing, condition, consequence or approval is required. | ||
|
|
||
| 8. | Representations and Warranties of the Sellers | |
| 8.1 | Schedule 8.1 sets forth the Representations and Warranties which the Sellers make jointly and severally in favor of the Purchaser (the Representations and Warranties). The Sellers, jointly and severally, represent and warrant that the Representations and Warranties are true, accurate and complete, without omitting any fact or circumstance which would alter, restrict or condition the content and scope of such Representations and Warranties. | |
| 8.2 | The Purchasers decision to purchase the Shares for the Purchase Price and upon the other terms established in this Agreement is based essentially on the existence, truthfulness, accuracy and completeness of the Representations and Warranties. | |
| 8.3 | On the basis of the foregoing and on the terms of Schedule 8.1, the Sellers shall be liable to the Purchaser for the truthfulness, accuracy, and completeness of the Representations and Warranties on the terms of clause 10. For the avoidance of doubt, the Sellers shall not be liable for the circumstances declared in the Disclosure Annexes, except if such circumstances are included in the Recoverable Exceptions. | |
| 8.4 | The completion by the Purchaser (or its advisors) of investigations and audits of the business, financial, accounting, environmental, information technologies and systems, legal and tax circumstances (due diligence) of some of the DME Group companies does not in any way exempt or limit the liability of the Sellers, except for matters A) declared in the Disclosure Annexes that are not included in the Recoverable Exceptions and B) covered by Clause 10.2 (iv) that are not included in the Recoverable Exceptios. |
17
| 8.5 | The Representations and Warranties shall be understood as referring to the Signing, unless express reference is made to another date. | |
| 8.6 | On the Closing Date the Sellers shall certify to the Purchaser the validity and effectiveness of the Representations and Warranties as of the Closing Date in accordance with the terms of Clauses 5.1.c) and 6.4.f). | |
|
|
||
| 9. | Representations and Warranties of the Purchaser | |
| 9.1 | Schedule 9.1 sets out the Representations and Warranties which the Purchaser makes in favor of the Sellers. The Purchaser represents and warrants that the Representations and Warranties of the Purchaser are true, accurate and complete, without omitting any fact or circumstance which would alter, restrict or condition the content and scope of such Representations and Warranties. | |
| 9.2 | On the Closing Date Purchaser shall certify to Sellers the validity and effectiveness of the Representations and Warranties. | |
|
|
||
| 10. | Obligation to Indemnify by the Seller | |
| 10.1 | Subject to the time limits set forth in Clause 11 of this Agreement, the Sellers shall jointly and severally ( Solidariamente ) indemnify and hold harmless the Purchaser from, against and in respect of any and all loss, including Taxes that might be imposed on Purchaser as a result of such indemnity, harm, prejudice, charge, responsibility, debt, capital loss, fine, surcharge, interest or expense (including fees and costs for lawyers, prosecutors, notaries, auditors, accountants, experts, appraisers or other professionals) caused by (i) breach, inaccuracy (whether caused by omission or otherwise) or untruthfulness of any of the Representations and Warranties which arose or resulted from any act, omission, fact or occurrence originating prior to Closing; or (ii) any Recoverable Exception; or (iii) breach of any other obligations, undertakings, provisions, terms and conditions or agreements set out in this Agreement; or (iv) non compliance with laws and regulations applicable to the construction, technical characteristics, area and security of real estate; or (v) the use of materials considered by competent authorities to be dangerous or prohibited for the construction of real estate (hereinafter Losses or Loss). For the calculation of Loss imposed on the Purchaser, DMEs ownership interest in Spria shall always be considered to be 50%. |
18
| 10.2 | For the avoidance of doubt, Losses shall not include, whatever their nature and amount might be, circumstances or obligations which (i) are duly reflected and supported in the Closing Consolidated and Individual Financial Statements but only up to the amount which has been accounted or provisioned for, as the case may be; (ii) are the object of express exemption from liability in this Agreement; (iii) are duly specified in the Disclosure Annexes, but only up to the amount which has been specified when applicable, in the respective Disclosure Annexes, provided always that they are not also included in the Recoverable Exceptions; (iv) are at the time of Signing actually known by the individuals named in Clause 4 of Schedule 9.1 to constitute a breach of Sellers Representations and Warranties, provided always that they are not also included in the Recoverable Exceptions; or (v) relate to damages to the reputation of the DME Group or the Purchaser. | |
| 10.3 | For the sake of further clarity in appropriate circumstances, Losses will be calculated in respect of Purchasers ownership interest acquired pursuant to this Agreement. For example, if a claim related to a 10 million euro obligation of DME, Purchasers Loss would be 6.83994 million euro (68.3994%) of the obligation. Conversely, if a claim related to a 10 million Euro defect in title of the Shares, Purchasers Loss would be 10 million Euro (100%). | |
| 10.4 | The amount of indemnity for each Loss is understood as being net of (a) any indirect Taxes payable by the Purchaser as a consequence of the indemnity and (b) the net amount of any recovery actually received under insurance policies of the DME Group. The amount of any Loss for which indemnification is provided under this Agreement will (i) be reduced to take account of any net Tax benefit, as and when actually included by the Group Company having the Loss or the Purchaser within the tax return corresponding to the fiscal period when the Loss is suffered, arising from (A) the incurrence or payment of any such claim or Tax and (B) any correlative adjustments or changes in Tax treatment that occur as a result of the adjustment or change giving rise to such Loss and (ii) increased to take account of any net Tax cost arising from the receipt of indemnity payments hereunder (including any Tax resulting from the payment required under this clause) included by the indemnified party within the tax return corresponding to the fiscal period when the indemnification is collected from the Sellers. | |
| 10.5 | Except for any amount required to be treated for Tax purposes as interest, all indemnity payments under Clause 10 of this Agreement will be treated as an adjustment to the Purchase Price paid for the Shares for tax purposes. |
19
| 11. | Time Limits Limitation of Liabilities Threshold | |
| 11.1 | Without prejudice to the provision set out in Clause 11.2, the limitation period ( plazo de caducidad" ) for all claims for Losses shall be three years from the Closing Date (Time Limit), unless the Purchaser has submitted to Sellers, on or before the Time Limit has elapsed, a Notice of Loss as defined in Clause 12.1.a. The Purchaser must initiate legal proceedings before a court of justice at the latest of (i) the Time Limit; or (ii) nine (9) months after the aforementioned written notice has been served to the Sellers. | |
| 11.2 | By way of exception to the foregoing, the limitation period for claims for Losses based on tax, labor and social security related matters and for Losses based on Sellers capacity and authority and Title to the Shares shall be the respective statute of limitation established by applicable law. For the sake of greater clarity, the Parties expressly state and acknowledge that, according to Spanish and Portuguese law, any claim made by the relevant competent authority or third party regarding any of the subject matters referred to in this Clause within the corresponding statute of limitations interrupts the applicable limitations period of each such claim until final settlement. | |
| 11.3 | Sellers obligation to indemnify, defend, or hold the Purchaser harmless from or against any Loss shall be limited to 39,000,000.00 (in words: Euro thirty nine million). This limitation shall not apply: (i) to any Loss arising out of a breach of the Representations and Warranties on Schedule 8.1 regarding A) Sellers capacity and authority to represent; or B) title to the Shares; or (ii) a breach of non-compete agreements referred to in Clause 13; or (iii) any failure of the Sellers to comply with the obligations undertaken pursuant to Clause 7.1.e). For the avoidance of doubt, amounts collected by Purchaser from Sellers for Losses other than those derived from (i), (ii) and (iii) above, shall reduce the maximum liability of the Sellers obligation to indemnify. | |
| 11.4 | Sellers obligation to indemnify shall accrue only if the aggregate of all Losses exceed the amount of 1,500,000.00 (in words: Euro One Million and five hundred thousand) (the Threshold). If the Losses exceed the Threshold, Sellers obligation for indemnification shall accrue for the full amount of all Losses and not only for the amount which exceeds the Threshold, and the procedures set out in Clause 12 shall apply. Notwithstanding the above, the Threshold does not apply to Losses in relation to all circumstances disclosed by Sellers in Annex 12.10 (i.e. the Loss shall be payable from the first euro). Payments by Sellers for such Losses in relation to all circumstances disclosed by Sellers in Annex 12.10, will not be considered for purposes of reaching or exceeding the Threshold. |
20
| 12. | Claims Procedure for Indemnity of Losses | |
| 12.1 | In the event of a Loss not arising from a claim by a third party, the following procedures shall be followed: |
| a. | The Purchaser, directly or through any other person acting on behalf of the Purchaser, acting with reasonable diligence from the date on which it had knowledge of the Loss, shall notify the Sellers of the existence of the Loss and the indemnity claimed (the Notice of Loss). By serving Notice of Loss, the Time Limit will no longer be applicable to such claim and, therefore, the Sellers will be liable vis-à-vis the Purchaser until a final settlement is reached in relation to such claim, either by mutual agreement or otherwise by firm, final and binding judicial resolution. | ||
| b. | The Notice of Loss shall include (i) a description of the Loss; (ii) the basis of the claim; and (iii) any other information or documentation reasonably available to the Purchaser on which Purchaser relies to substantiate its claim. | ||
| c. | Within (10) Business Days from receipt of the Notice of Loss, the Sellers shall notify the Purchaser of (i) their acceptance of the claim and their obligation to pay the corresponding amount of the Loss in accordance with the Purchasers claim, or (ii) their rejection, whether in whole or in part, of the claim for the amount of the Loss. | ||
| d. | In the circumstance provided for in Clause 12.1c)(i), the Sellers shall pay to the Purchaser the amount of the Loss within thirty (30) calendar Days following the end of the aforementioned period for responding to the Notice of Loss. | ||
| e. | Sellers rejection of a claim (partially or totally) pursuant to Clause 12.1c)(ii) shall not prejudice or limit whatsoever the Purchasers rights to indemnification pursuant to Clause 10 or Purchasers rights to pursue a claim against the First Demand Bank Guarantee. | ||
| f. | If, within the ten (10) Business Days following receipt of the Notice of Loss, Sellers have not delivered their response to the Purchaser, the Sellers shall be deemed to have rejected the claim as well as their obligation to pay the amount of the Loss as claimed by the Purchaser. |
21
| 12.2 | In the event of a Loss arising from a claim by any third party including any tax authorities, labor, social security, administrative or other government entity, and whether through judicial or administrative proceedings, whether by judicial or extrajudicial means (Third Party Claim) against the Purchaser or any company in the DME Portfolio (hereinafter the Affected Company), the following procedure shall apply: |
| a. | The Purchaser, directly or through any third entity acting on behalf of Purchaser, shall serve Notice of Loss to the Sellers of such Third Party Claim, requesting that it be indemnified. | ||
| b. | The Notice of Loss shall include (i) a copy of the document, if any, which contains the Third Party Claim or a copy of the document, if any, pursuant to which a tax audit, inspection or review was commenced, or on which the claim is based, as the case may be; (ii) a description of the Loss; and (iii) any other information on which Purchaser relies to substantiate its claim. The Notice of Loss shall be accompanied by reasonable supporting documentation that is reasonably available to Purchaser. | ||
| c. | Within the ten (10) Business Days following receipt of the Notice of Loss, the Sellers shall notify the Purchaser (i) if they reject that a Loss could eventually arise from the Third Party Claim, or (ii) if they accept that a Loss could eventually arise from the Third Party Claim. | ||
| d. | The Affected Company shall have the right to exercise the defense which it considers most convenient, including the acceptance or opposition to the claim, or the settlement thereof, whether it be judicial or extra-judicial, without the Sellers having the right to limit in any way this right of the Affected Company, in each case without prejudice to any other rights that Purchaser may have under this Agreement or applicable law, the Purchasers right to commence, at any time starting from the Sellers response, legal proceedings. The Sellers, directly or through their designated advisors, shall have the right to be periodically informed of the development of the claim involved. | ||
| e. | In the circumstance provided for in Clause 12.2(c)(ii), the Sellers shall include in their response an express indication of their instructions to the Purchaser as to whether (i) they accept the amount of the Third Party Claim stating in the response that the Sellers shall take responsibility for the amount of such claim pursuant to Clause 10; or (ii) they reject the amount of the Third Party Claim, stating in the response the amount, if any, that they accept and their reasons for rejecting the balance. In the event Sellers object to the amount of the Third Party Claim, and subject in all cases to the |
22
| right of Purchaser or the Affected Company, as the case may be, to control the defense to such Third Party Claim as provided in 12.2 (d) above, (A) Purchaser and Sellers shall cooperate in the conduct of any proceeding relating to such claim, (B) Sellers shall have the right to participate in such proceeding at Sellers expense. If the Affected Company enters into any settlement agreement without the consent of Sellers, and the Purchaser exercises its right to claim a Loss, Sellers may initiate an action in a court of competent jurisdiction against Purchaser to recover from Purchaser the amount of the settlement claimed by Purchaser as a Loss in excess of what Sellers believe is reasonable. If Sellers prevail in such action, Purchaser shall repay to Sellers the amount of the Loss determined by the court to be in excess of a reasonable settlement; the non-prevailing party shall pay all the costs of such litigation, including reasonable attorney fees for both parties. | |||
| f. | If within the ten (10) Business Days following receipt of the Notice of Loss the Sellers have not notified the Purchaser of their response, or their response is not one of those provided for in Clause 12.2(c), they shall be deemed to have rejected the Loss deriving from the Third Party Claim, and shall be subject to the same regime as provided for in Clause 12.2 (d). | ||
| g. | Notwithstanding any provisions to the contrary contained in this Agreement, Purchaser shall have the sole right to control and make all decisions regarding the DME Group Company interests in any Tax audit or administrative or court proceeding relating to Taxes, including selection of counsel and selection of a forum for such contest, provided, however, that in the event such audit or proceeding relates to Taxes for which Sellers are responsible and have agreed to indemnify Purchaser pursuant to Clause 10.1 hereof, (A) Purchaser and Sellers shall cooperate in the conduct of any audit or proceeding relating to such Taxes, (B) Sellers shall have the right to participate in such audit or proceeding at Sellers expense, (C) Purchaser shall not enter into any agreement with the relevant taxing authority pertaining to such Taxes without the written consent of Sellers, which consent shall not unreasonably be withheld, and (D) Purchaser may, without the written consent of Sellers, enter into such an agreement provided that Purchaser shall have agreed in writing to forego any indemnification under this Agreement with respect to such Taxes. In the event of any conflict between the provisions of this Clause 12.2 g. and any other provision of this Agreement, the provisions of this Clause 12.2 g. shall control. |
23
| 13. | Sellers Non-Competition | |
| 13.1 | On or before Closing Date, each of the Sellers shall have entered into separate, binding non-competition agreements with the Purchaser in the form of Schedule 13 to this Agreement. Such non-competition agreements to extend from the Closing Date and until the fifth (5th) anniversary of the Closing Date (hereinafter, this period shall be referred to as the Non-Competition Period). | |
| 13.2 | In the event that any of the Sellers breaches the aforementioned obligations during the Non-Competition Period, the Purchaser will have the right to recover from Sellers for each breach the greater of: (a) damages and losses arising from the breach; or (b) the amount of 5,000,000.00 (in words: five million euros). The Sellers expressly recognize the essential nature of the non-competition and confidentiality obligation and compliance therewith for the Purchasers decision to enter into this Agreement. | |
|
|
||
| 14. | Confidentiality | |
| 14.1. | Except for the press notices concerning the Transaction made in accordance with Clause 14.2 (and only to the extent of the information disclosed in such notices) and the required filings with the European Commission, the Parties agree to maintain this Agreement confidential, with regards to its object, terms, and conditions, and the documents and information resulting from this Agreement, such that the Parties shall not have the right to reveal any of their terms to any Person, other than such Persons forming part of its management bodies or senior management, or those who participate professionally in this Transaction as legal, accounting, financial or other advisors, or unless required to disclose such information by any regulatory body, inspector or supervisor, or due to any judicial ruling. | |
| 14.2. | In the event of disclosure required by applicable law, the Party required to disclose shall inform the other Parties of the content of the information to be disclosed prior to its disclosure, and to the extent possible, shall comply with the reasonable requests which such Parties may make. The content of any press notices or promotional communications, whether commercial or analogous, whatever might be the media for its disclosure, shall be agreed to in writing by the Parties before its communication or disclosure. Specifically, the Parties agree that Purchaser may file the Agreement with the Securities and Exchange Commission of the United Sates of America in Washington, D.C., United States of America, and such filings and disclosure of information pertaining to such filings will not constitute a breach by the Purchaser of this Clause 14. |
24
| 15. | Actions After Closing | |
| 15.1. | After the Closing Date, Sellers will, without further cost or expense to Purchaser, execute and deliver to Purchaser (or cause to be executed and delivered to Purchaser), such additional instruments of conveyance, and Sellers shall take such other and further actions as Purchaser may reasonably request to complete the legal formalities necessary to sell, transfer, and assign to Purchaser and vest in Purchaser title to the Shares and to vest in the DME Portfolio assets necessary to conduct its business in future as it is currently being conducted. | |
| 15.2. | As and to the extent Sellers shall have failed to obtain prior to Closing Date the consent or approval (or an effective waiver thereof) of any person or persons in respect of any item described in Clause 6.4 hereof, after the Closing Date: |
| (a) | the Parties will use their best efforts to obtain from such person or persons the consents or approvals (or effective waivers thereof); and | ||
| (b) | if the Parties are unable to obtain any such consent, approval, or waiver, then (1) this Agreement shall not constitute or be deemed to be a contract to assign the same if an attempted assignment without such consent, approval, or waiver would constitute a breach of such item or create in the issuer or any party thereto the right or power to cancel or terminate such item and (2) Sellers will cooperate with Purchaser in any reasonable arrangement designed to provide Purchaser with the benefit of Sellers rights under such item, including enforcement (at Purchasers expense) of any and all rights of Sellers against such person as Purchaser may reasonably request. |
| 15.3. | Sellers shall provide Purchaser and its subsidiaries with information and assistance necessary to permit the Activities of the DME Group to continue during the transition period after Closing without interruption and without being adversely affected by the Transaction. | |
| 16. | Bank Guarantee ( Aval a primer requerimiento ) | |
| 16.1. | Sellers First Demand Bank Guaranty |
| a. | All obligations of the Sellers pursuant to this Agreement shall be covered by the First Demand Bank Guarantee ( Aval a primer requerimiento ), to be provided by Sellers substantially in the form set out in Schedule 16.1. |
25
| b. | First Demand Bank Guarantee means a guarantee delivered by a reputable international bank, reasonably acceptable to the Purchaser, to cover all obligations of the Sellers pursuant to this Agreement. The First Demand Bank Guarantee shall be issued at the latest on the Closing Date and shall be limited to the amount of 39,000,000.00 (in words: Euro thirty nine million). The Guarantee shall be enforceable for a period of three years and three months from the Closing Date. If at such Date there are unresolved disputes between the Parties, the First Demand Bank Guarantee will be extended, in the value of the dispute between the Parties, until final resolution of the dispute between the Parties. |
| 16.2. | Purchasers Bank Guaranty |
| a. | Obligations of the Purchaser pursuant to Clauses 7.5 and 7.6 of this Agreement shall be covered by Purchasers Bank Guarantee, to be provided by Purchaser substantially in the form set out in Schedule 16.2. | ||
| b. | The Purchasers Bank Guarantee means a guarantee delivered by the Spanish branch or subsidiary of a reputable international bank, reasonably acceptable to the Sellers, to cover the obligations of the Purchaser pursuant to Clause 7.5 in this Agreement. The Purchasers Bank Guarantee shall be issued at the latest on the Signing and shall be limited to the amount of 10,000,000.00 (in words: Euro Ten million). The Purchasers Bank Guarantee shall be enforceable for a period of six months from the Closing Date. If at such Date there are unresolved disputes between the Parties, the Purchasers Bank Guarantee will be extended, in the value of the dispute between the Parties, until final resolution of the dispute between the Parties. Sellers will return Purchasers Bank Guarantee to Purchaser (i) upon effective transfer of shares; or (ii) one month after the Transaction is rejected by the competent antitrus authorities, unless during that period Sellers have filed a claim before competent courts of justice pursuant to Clause 18.2 for breach of Purchasers obligation under clause 7.6 of this Agreement. |
| 17. | Miscellaneous | |
| 17.1. | Notices |
| a) | All notices or communications which the Parties must make under this Agreement shall be made in writing, both in English and Spanish and shall |
26
| be delivered (i) by personal delivery with written confirmation of receipt by the other Party; (ii) by notaries service made by a Spanish notary; (iii) by burofax; (iv) by electronic mail (email) with a written copy sent by registered mail, or (v) by any other means which leaves certifiable evidence of its receipt Date by the addressee(s). | |||
| b) | Notices and communications among the Parties shall be delivered to the addresses and to the attention of the persons indicated in Schedule 17.1 (b) of this Agreement. | ||
| c) | Any change to the addresses for notices shall be immediately communicated to the other Parties in accordance with the rules set out in this Clause. Until a Party receives notice of a change of address from the other Parties, any notices sent to the previous address shall be valid. |
| 17.2. | Entire Agreement; Severability |
| a) | This Agreement contains the entire agreement among the Parties in regards to the subject matter which constitutes its object, and supersedes all prior agreements or prior pre-contractual undertakings, whether verbal or written, which could bind the Parties in relation to this matter, including without limitation the Letter of Intent and the Term Sheet. | ||
| b) | If any of the provisions of this Agreement were declared void or invalid, such declaration shall not affect the remaining provisions. The Parties shall be freed from all rights and obligations which derive from the provision declared void or invalid, but only to the extent that these rights and obligations are directly affected by such voidance or invalidity. In this event, the Parties shall negotiate in good faith to substitute the void or invalid provision with another valid and effective provision which sets out, to the extent possible, the original intention of the Parties. |
| 17.3. | Amendments and Waivers |
| a) | This Agreement shall not be modified except by means of a written instrument signed by all Parties hereto containing an express and unequivocal |
27
| statement of the amendment agreed upon and explicitly referring to the provision to be amended. | |||
| b) | The failure by a Party to exercise any right under this Agreement shall not be considered as a waiver of such right and shall not inhibit in any way the subsequent exercise of such right by such Party. |
| 17.4. | Expenses and Taxes | |
| The expenses and Taxes resulting from the negotiation, formalization, execution, and Closing of this Agreement shall be borne by the Parties as indicated below: |
| a) | The notary fees related to the formalization this Agreement and the Closing shall be borne by Purchaser. | ||
| b) | The filing fees related to the fulfillment of the Condition Precedent set out in Clause 5.1a) shall be borne by Purchaser. | ||
| c) | The fees of advisors, auditors and other professionals shall be borne by the Party that in each case contracted such advisors. | ||
| d) | The Taxes which result from the formalization, execution and Closing of this Agreement shall be borne by the Parties as determined by law. |
| 17.5. | Communication |
| a) | Except as required by law, no public announcements or press releases concerning the sale and transfer of the Shares shall be made by either Party without the prior written consent of the other Party. | ||
| b) | Purchaser and Sellers agree to use their best efforts to develop a joint communication plan and to cooperate fully in determining the location, time and manner of disclosing the formation pertaining to the transactions contemplated by this Agreement to customers, suppliers and employees. | ||
| c) | Sellers shall not make any declarations to third parties, whether verbal or written, in public or in private, which would be expected to negatively |
28
| affect the DME Portfolio, Purchaser or its subsidiaries or their respective employees or operations. |
| 17.6. | Assignment | |
| The Parties shall not assign this Agreement or any part hereof without the written consent of the other Party hereto. Sellers, however, hereby consent to the total or partial assignment by Purchaser of this Agreement to any affiliate of TRW, under the condition that Purchaser remain jointly and severally liable for any money payments to be made to Sellers under this Agreement (and any of the Exhibits of this Agreement). | ||
| This Agreement shall be binding on and accrued to the benefit of the Sellers, their heirs and successors. | ||
| 18. | Governing Law and Jurisdiction | |
| 18.1. | This Agreement shall be governed and interpreted in accordance with the laws of the Kingdom of Spain. | |
| 18.2. | The Parties expressly agree to submit all conflicts resulting from the execution or interpretation of this Agreement to the courts and tribunals of the city of Madrid, with express waiver of their own forum, if they have a right to such other forum. | |
| 19. | Language | |
| 19.1. | This Agreement shall be signed in both Spanish and English Language. In the event of a conflict between the Spanish and English Versions the terms of the Spanish version shall prevail. |
29
|
THE SELLERS
|
||||
|
|
||||
|
Ms. Nuria Castellón García
|
Mr. Luis Gras Tous | |||
|
|
||||
|
|
||||
|
Signature
|
Signature | |||
|
|
||||
|
Ms. Maria Luisa Gras Castellón
|
Mr. José Ramón Sanz Pinedo | |||
|
|
||||
|
|
||||
|
Signature
|
Signature | |||
|
|
||||
|
THE PURCHASER
|
||||
|
|
||||
|
TRW Automotive Inc.
|
Automotive Holdings (Spain), S.L. | |||
|
|
||||
|
|
||||
|
Mr. Guenter Brenner
|
Mr. Roderick McLaren |
30
|
Schedule I:
|
Shares owned by the Sellers in the DME Group | |
|
|
||
|
Schedule II:
|
Shares owned by DME in DME Portfolio | |
|
|
||
|
Schedule 1.1:
|
Definitions | |
|
|
||
|
Schedule 2.1:
|
Title of Shares | |
|
|
||
|
Schedule 4.2:
|
Instructions to the Escrow Agent | |
|
|
||
|
Schedule 4.2.b):
|
Payment Details | |
|
|
||
|
Schedule 4.3.d):
|
Base-Line Net Book Value | |
|
|
||
|
Schedule 6.4 c):
|
Form of certificate of compliance with obligations during the Interim Period | |
|
|
||
|
Schedule 6.4 d):
|
Form of certificate of compliance with requirements of the articles of association for the transfer of Shares of DME | |
|
|
||
|
Schedule 6.4 e):
|
Form of certificate of validity of the Representations and Warranties | |
|
|
||
|
Schedule 6.4.j):
|
Letter related to the lease agreement | |
|
|
||
|
Schedule 7.2:
|
Actions Prior to Closing | |
|
|
||
|
Schedule 8.1:
|
Representations and Warranties of the Sellers | |
|
|
||
|
Schedule 9.1:
|
Representations and Warranties of Purchaser | |
|
|
||
|
Schedule 13:
|
Form of non-competition Agreements | |
|
|
||
|
Schedule 16.1:
|
Form of Sellers First Demand Bank Guarantee | |
|
|
||
|
Schedule 16.2:
|
Form of Purchasers Bank Guarantee | |
|
|
||
|
Schedule 17.1 (b):
|
Notices |
31
|
Activities of the DME
Group:
|
Means the activities of DME Group as defined in Recital IV. | |
|
|
||
|
Adjustments:
|
Means the adjustments to be done to the Purchase Price as described in Clause 4.3. | |
|
|
||
|
Affected Company
|
Has the meaning provided for in Clause 12.2 | |
|
|
||
|
Agreement:
|
Means this document with all the attachments, annexes and schedules thereto. | |
|
|
||
|
Auditors Report:
|
Has the meaning provided for in Clause 4.3 a) | |
|
|
||
|
Auditors:
|
Means the auditor referred to in Clause 4.3 a) | |
|
|
||
|
Bank:
|
Means [first line bank operating in Spain to be determined by the Parties before Closing] Bank. | |
|
|
||
|
Base-Line Net Book
Value:
|
Has the meaning set out in Clause 4.3 d) | |
|
|
||
|
Business Day:
|
Means any day not a Saturday, Sunday or holiday (whether a national, regional or local holiday) in Madrid, Spain. | |
|
|
||
|
Closing:
|
Means the time when the Shares are transferred and the other actions provided for in clause 6.4 are completed. | |
|
|
||
|
Closing Assets:
|
Has the meaning provided in clause 4.3. a) | |
|
|
||
|
Closing Balance Sheet:
|
Has the meaning provided in clause 4.3. a) | |
|
|
||
|
Closing Date:
|
Means the date determined in accordance with the terms of clause 6.1. |
32
|
Closing Financial
Statements
|
Means individual and consolidated financial statements of the DME Group companies prepared by the Company as of and for the period ended on the Closing Date. | |
|
|
||
|
Closing Liabilities:
|
Has the meaning provided in clause 4.3. a) | |
|
|
||
|
Closing Net Book
Value:
|
Is the figure resulting from the calculation pursuant to Clause 4.3.e) | |
|
|
||
|
Conditions Precedent:
|
Means the conditions precedent described in clause 5 of this Agreement. | |
|
|
||
|
Consolidated Financial
Statements:
|
Means the consolidated balance sheet, consolidated profit and loss account, the consolidated notes to the financial statements ( memoria ) of the DME Group on the Reference Date of the Financial Statements which are attached hereto as Annex 7.1 to Schedule 8.1 . | |
|
|
||
|
Controlled
Subsidiaries:
|
Has the meaning described in Recital III (i) | |
|
|
||
|
Disclosure Annexes:
|
Means each and every one of the Annexes to Schedule 8.1 in which the Sellers set out the exceptions to the Representations and Warranties. | |
|
|
||
|
DMB:
|
Means the Brazilian company DALPHI METAL BRASIL, L.T.D.A., registered at the Commercial Registry of Parana (Brasil), having its registered office at Rua Marechal Deodoro 630-17º Andar, Conjunto 1708 Curitiba, Estado do Parana (Brasil), and holding Tax Identification Number (CEP) 80.010-912. | |
|
|
||
|
DME:
|
Means the Spanish company DALPHI METAL ESPAÑA, S.A., registered at the Commercial Registry of Madrid, at tome 1,548, page M-28447, having its registered office at calle Mártires Concepcionistas, 3, 28006 Madrid, and holding Tax Identification Number ( NIF ) A-36610244. | |
|
|
||
|
DME Group:
|
Has the meaning provided for in Recital III (ii) |
33
|
DME Portfolio:
|
Has the meaning as defined in Recital III | |
|
|
||
|
DME Shares:
|
Means the 19.760 bearer shares in DME, each having a par value of 30.05, representing the whole of the share capital of DME, numbered consecutively from 1 to 1 to 19.760, both inclusive. | |
|
|
||
|
DMI:
|
Means the Spanish company DALPHI METAL INTERNACIONAL, S.A., registered at the Commercial Registry of Madrid, at tome 1,584, , page M-29000, having its registered office at calle Mártires Concepcionistas, 3, 28006 Madrid, and holding Tax Identification Number ( NIF ) A-36643997. | |
|
|
||
|
DMI Shares:
|
Means the 60,000 nominative shares in DMI, each having a par value of 30.05, representing the whole of the share capital of DMI, numbered consecutively from 1 to 60,000, both inclusive. | |
|
|
||
|
DMP:
|
Means the Portuguese company DALPHI METAL PORTUGAL,S.A., registered at Conservatoria do Registro Comercial de Vila Nova de Cerveira, with registration number 142/920413, having its registered office at Zona Industrial de Vila Nova de Cerveira, Freguesia de Campos, Concelho de Vila Nova de Cerveira (Portugal), and holding Tax Identification Number 502764252. | |
|
|
||
|
DMP Shares:
|
Means the 30,000 nominative shares in DMP, each having a par value of 49.88, representing the whole of the share capital of DMP, numbered consecutively from 1 to 30,000, both inclusive. | |
|
|
||
|
DMS:
|
Means the Spanish company DALPHI METAL SEGURIDAD, S.A., registered at the Commercial Registry of Madrid, at tome 10,214, page M-161626, having its registered office at calle Mártires Concepcionistas, 3, 28006 Madrid, and holding Tax Identification Number ( NIF ) A-81300188. | |
|
|
||
|
DMS Shares:
|
Means the 16,000 nominative shares in DMS, each |
34
|
|
having a par value of 601.01, representing the whole of the share capital of DMS, numbered consecutively from 1 to 16,000, both inclusive. | |
|
|
||
|
DMT:
|
Means the Tunisian company DALPHI METAL TUNISIE, S.A.R.L., registered at the Commercial Registry of Túnez, at volume 67, Serie A, Case 254, having its registered office at 38, Rue de Bône-ZI Ben arous-2013, Tunis, and holding Tax Identification Number (Matricula Fiscal) 745173L. | |
|
|
||
|
Due Diligence:
|
Has the meaning described in Clause 8.4. | |
|
|
||
|
Escrow Fund:
|
Has the meaning described in Clause 4.2 | |
|
|
||
|
First Demand Bank
Guarantee
|
Means the Bank Guarantee foreseen in Clause 16.1 | |
|
|
||
|
Individual Financial
Statements:
|
Means, in respect of each of the companies in the DME Group, in each case, the balance sheet, profit and loss account, the notes to the financial statements ( memoria ) [and the management report] of each of the DME Portfolio on December 31, 2004 which are attached hereto as Annex 6.1 to Schedule 8.1 . | |
|
|
||
|
Intellectual or
Industrial Property
Rights:
|
Means: (i) inventions, discoveries, processes, designs, techniques, developments, technology, and related improvements, whether or not patentable; | |
|
|
||
|
|
(ii) patents, utility models and certificates of inventorship for inventions and applications therefore, including reissues, renewals, re-examinations and extensions thereof; | |
|
|
||
|
|
(iii) industrial designs; | |
|
|
||
|
|
(iv) distinctive signs (under Spanish law) and trademarks (under European Community law and under the national laws of other countries), trade dress, service marks, service names, trade names, brand names, logos or business symbols, whether registered or unregistered, and pending applications to register |
35
|
|
the foregoing, including extensions and renewals thereof and goodwill associated therewith; | |
|
|
||
|
|
(v) technical, scientific, and other know-how, trade secrets, methods, processes, practices, formulas and techniques, blueprints, industrial drawings, diagrams of integrated circuits, computer software programs and software systems, including all databases, compilations, tool sets, compilers, higher level or proprietary languages, related documentation and materials, whether in interpretive code, source code, object code or human readable form; | |
|
|
||
|
|
(vi) copyrights in writings, designs, software, mask works or other works, whether registered or unregistered, and pending applications to register the same (including moral rights and other authors rights, rights of publicity and privacy, name and likeness rights and other similar rights); | |
|
|
||
|
|
(vii) domain names; and | |
|
|
||
|
|
(viii) any other analogous rights not indicated in the preceding points in this definition. | |
|
|
||
|
Interim Period:
|
Means the period of time between the Signing and the Closing Date. | |
|
|
||
|
Letter of Intent
|
Means the letter of intent entered by the Parties on May 10, 2005 before the Spanish Notary Mr. Segismundo Álvarez Royo-Vilanova. | |
|
|
||
|
Loss or Losses:
|
Means the damages and losses as defined in clause 10. | |
|
|
||
|
Material Adverse
Change:
|
Means any material adverse change, or any event, circumstance, condition or matter that has caused or resulted in, or is reasonably likely to cause or result in, a material adverse change, in the business, properties, results of operation, condition (financial or otherwise), assets or liabilities of the DME Portfolio taken as a whole; provided, however, that Material Adverse Change shall not include any change resulting |
36
|
|
from (i) announcement of the execution of this Agreement and the transactions contemplated hereby or (ii) general economic or political conditions or other conditions affecting the industry in which the DME Group operates. | |
|
|
||
|
Non-Competition
Agreements:
|
Means the agreements referred to in Clause 13.1. | |
|
|
||
|
Non-Competition
Period:
|
Means the time period determined in accordance with the clause 13.1. | |
|
|
||
|
Notice of Loss:
|
Means any of the notices described in clause 12.1 a) | |
|
|
||
|
Ordinary Course of
Business:
|
Means the acts or omissions of each of the companies in
the DME Group which satisfy each of the following
requirements:
(i) such acts or omissions consistent with (in their nature, amount and economic content) the practices followed by the relevant DME Group company prior to the Signing; |
|
|
|
||
|
|
(ii) which do not require the approval or resolution of the General Meeting of Shareholders, Board of Directors, Executive Committee or the Managing Director of any of the companies in the DME Group; and | |
|
|
||
|
|
(iii) due to their nature do not have an extraordinary character or special relevance in respect of the normal development of the economic or business activity of the DME Portfolio. | |
|
|
||
|
Other Participations
|
Has the meaning described in Recital III (iii). | |
|
|
||
|
Parties:
|
Means collectively the Sellers and the Purchaser. | |
|
|
||
|
Person:
|
Means a natural or legal person. | |
|
|
||
|
Personal Rights:
|
Means any restriction, obligation or defect having a personal nature which encumbers (i) the title to the asset, its peaceful and full possession, (ii) the capacity of the transferor to freely dispose of the asset, or (iii) any other right inherent in its title. Personal Charges |
37
|
|
includes preferential acquisition rights, rights of first refusal, buy-back rights, obligations to offer, option rights, limitations on use, disposition or enjoyment, or any other limitations of rights inherent in the ownership of the asset in question, whether they be in the articles of association or of a voluntary, legal or contractual nature, or other charges, restrictions, encumbrances of a personal nature. | |
|
|
||
|
Personnel:
|
Means all of the employees of the companies of DME Group. | |
|
|
||
|
Post Closing
Adjustments:
|
Has the meaning set out in Clause 4.3. | |
|
|
||
|
Purchase Price:
|
Means the consideration of the purchase and sale of the Shares of DME determined pursuant to the terms of clause 4.1 | |
|
|
||
|
Purchaser:
|
Means jointly TRW Automotive Inc. and Automotive Holdings (Spain), S.L. as described in the introduction to the Parties of this Agreement. | |
|
|
||
|
Real Rights (
derechos
reales)
:
|
Means any restriction, obligation or defect of a real nature which encumbers (i) title to an asset, its peaceful enjoyment and full possession, or (ii) the capacity to freely dispose of it, or (iii) any other right inherent in its title. Such term includes mortgages, pledges, usufructs, rights of anticresis, servitudes, rights of use, rights of census, retention rights, pre-emptive entries in any public registries, and other charges, restrictions and encumbrances of a real nature. | |
|
|
||
|
Recoverable
Exceptions:
|
Means the list of matters, actions and events set forth in Schedule 9.1 or expressly qualified as such in any other place, which are subject to being indemnified by the Sellers on the terms of clause 8.4 even when they appear in the Disclosure Annex. | |
|
|
||
|
Relevant Companies:
|
Has the meaning set out in Recital III (ii) | |
|
|
||
|
Representations and
Warranties of Seller:
|
Means the representations and warranties of the Sellers set forth in Schedule 8.1. |
38
|
Sellers:
|
Means (i) Ms. Nuria Castellón García; (ii) Mr. Luis Gras Tous; (iii) Ms. María Luisa Gras Castellón; and (iv) Mr. José Ramón Sanz Pinedo as described in the introduction to the Parties of this Agreement, and all and any of their heirs or successors. | |
|
|
||
|
Shares:
|
Means the DME Shares. | |
|
|
||
|
SB:
|
Means the Portuguese company SAFE BAG, Industria Componentes de Segurança Automovel, S.A., registered at Conservatoria do Registro Comercial de Ponte de Lima with registration number 01332/20040121, having its registered office at Zona Industrial Gemieira, Lotes quinza a vinte, Freguesia da Gemieira, Concelho de Ponte de Lima (Portugal), holding Tax Identification Number 506832376. | |
|
|
||
|
SL:
|
Means the Portuguese company SAFE LIFE, Industria Componentes de Segurança Automovel, S.A. , registered at the Commercial Registry of Conservatoria do Registro Comercial de Vila Nova de Cerveira, with registration number 308/250200, having its registered office at Zona Industrial Gemieira, Lotes quinza a vinte, Freguesia da Gemieira, Concelho de Ponte de Lima (Portugal), holding Tax Identification Number 504822268. | |
|
|
||
|
Signing:
|
Means the date of execution of this Agreement, which appears at the top of this document. | |
|
|
||
|
Taxes:
|
Means any tax, levy, assessment, customs duties, rate, fee, charge or any kind or amount of encumbrance of any analogous nature, required by any administrative authority, including surcharges, interests and penalties which are due. | |
|
|
||
|
Term Sheet
|
Means the term sheet provided by Purchaser to Sellers on date May 10 th , 2005 during the negotiation of this Agreement. | |
|
|
||
|
Third Party Claim:
|
Shall have the meaning described in Clause 12.2 |
39
| 1. | Sellers Capacity and Authority to Represent |
| 1.1 | The Sellers have sufficient legal capacity to execute this Agreement and to perform the obligations deriving therefrom. |
| 1.2 | Except for the Conditions Precedent provided for in clause 5, the Sellers have obtained all approvals, permits and authorizations, whether pursuant to law, regulation, administrative law, articles of association, or contractual obligations, necessary to enter into this Agreement and to perform the obligations deriving therefrom. |
| 1.3 | The execution and performance of this Agreement by the Sellers does not: |
| a) | Breach any obligation, whether verbal or written, of any of the Sellers or of any DME Group companies; | ||
| b) | Breach any law, regulation, or any other legal rule developing such regulation passed by the competent authorities; or | ||
| c) | Breach of any court judgment, ruling, decree, order, restraining order, writ, injunction, arbitration rule or ruling of any other nature whatsoever issued by any judicial or administrative authorities, or in any arbitration proceedings to which the Sellers are a party, or which may affect their assets and rights. |
| 2. | Title to the Shares |
| 2.1 | The Sellers respectively own full legal title to the Shares referred to in Schedule I to the Agreement, by valid and lawful title, with all its rights, free and clear of any liens or encumbrances. |
| 2.2 | There are no Real Rights (Derechos Reales) which affect the Shares. |
| 2.3 | There are no Personal Rights ( Derechos Personales ) which affect the Shares and the Shares are not subject to any claim, encumbrance, option or similar restriction. | |
| 2.4 | There are no limitations on the transfer of the Shares. | |
| 2.5 | The Shares have been validly issued and are fully subscribed and paid-up. | |
| 2.6 | The Sellers have not acquired the Shares with the use of prohibited financial assistance. | |
| 2.7 | The representations and warranties of clauses 2.1 through 2.3, 2.5 and 2.6 above shall also apply to all shares that DME owns in each of DME Portfolio companies. Regarding 2.4 it shall also apply to all companies in the DME Portfolio except for those listed in Disclosure Annex 2.7 . | |
| 3. | Share Capital | |
| 3.1 | The share capital of each of the DME Group companies is set out in Disclosure Annex 3.1 . | |
| 3.2 | No corporate resolutions have been adopted which are pending execution which would cause any variation in the share capital of DME Group companies, whether through the creation of new shares or the redemption, whether total or partial, of the Shares, nor the refunding of any shareholder contributions, except for those described in Disclosure Annex 3.2 | |
| 3.3 | There are no options, subscription rights, warrants, convertible or tradable securities, or other rights (of any nature whatsoever) giving any right to subscribe or acquire shares of the DME Group companies. | |
| 3.4 | None of the DME Group companies hold any of their own shares or units ( autocartera ) nor shares or units in their respective parent companies. |
| 3.5 | To the best of the Sellers knowledge representations set out in sections 3.1 to 3.4 above are also true of the Other Participations, except for the case of NIHON PLAST as described in Disclosure Annex 3.5 . | |
| 4. | Incorporation, Valid Existence and Capacity | |
| 4.1 | The DME Group companies are duly incorporated, validly existing and in good standing and registered with the competent public registries and have full legal personality under their respective laws of incorporation. | |
| 4.2 | The corporate object of each of DME Group companies is sufficient for undertaking their respective businesses and activities and entitles them to operate and to carry on their activities in the form they have undertaken to date. | |
| 4.3 | To the best of the Sellers knowledge representations set out in sections 4.1 and 4.2 above are also true of the Other Participations. | |
| 5. | Articles of Association, Minutes, Company Books and Accounts, Deposit of Accounts | |
| 5.1 | The articles of association of the DME Group companies are those registered with the competent Commercial Registry where applicable and are in accordance with applicable law. There has been no action taken, nor is action pending to amend or restate the articles of association of any DME Group company, except as disclosed in Disclosure Annex 5.1 . No DME Group company is in default or violation of its articles of association. | |
| 5.2 | The minutes reflect all the matters dealt with and the resolutions adopted by the corresponding management bodies in their respective meetings, having been signed by all persons legally required to do so, and duly transcribed in their entirety into the minutes books of DME Group companies without any omissions. | |
| 5.3 | The minutes books DME Group companies are duly legalized, contain all the resolutions adopted by their respective general meetings of shareholders and management bodies, and are located at the offices of the respective DME Group companies, except as disclosed in Disclosure Annex 5.3 . |
| 5.4 | All resolutions adopted by the general meetings of shareholders or the management bodies of DME Group companies which have to be filed in the competent Commercial Registry and, as the case may be, other competent public registries, have been duly registered. | |
| 5.5 | The accounting books of the DME Group companies are duly legalized, have been kept in an orderly and diligent manner, are duly updated, and their content and form complies with applicable law and with the applicable GAAP in each corresponding jurisdiction. | |
| 5.6 | The other books which the DME Group companies are required by law to keep have been duly legalized, have been kept in an orderly and diligent manner, contain all the information required by law, and are located at the offices of the respective DME Group companies. | |
| 5.7 | The DME Group companies have complied, in a timely manner and in due form, with the legal obligation to deposit their annual accounts with the Commercial Registry, where applicable. | |
| 6. | Individual Financial Statements | |
| 6.1 | Disclosure Annex 6.1 sets out the Individual Financial Statements of each DME Group companies. | |
| 6.2 | The Individual Financial Statements have been prepared based upon the information set out in the accounting books of the respective DME Group companies. The Individual Financial Statements have been prepared in accordance with generally accepted accounting principles in the respective countries of DME Group companies and, as consistently applied and including those variations and interpretations described in an exhibit to that entitys financial statements (GAAP). The application of the respective countrys GAAP to the Individual Financial Statements has been consistent with that undertaken in prior fiscal years. | |
| 6.3 | The Individual Financial Statements fairly, faithfully and accurately reflect the assets, liabilities, financial condition and profits of the respective DME Group companies. |
Page 4/28
| 6.4 | The provisions reflected in the Individual Financial Statements have been determined in accordance with applicable national GAAP. | |
| 6.5 | The depreciations reflected in the Individual Financial Statements have been determined in accordance with applicable national GAAP. | |
| 6.6 | The Individual Financial Statements reflect all liabilities of each of the DME Group companies, the total amounts of which are duly accounted for. | |
| 6.7 | There has been no reevaluation of assets except upon application of the rules governing reevaluation and reappraisal. In such cases, such rules have been strictly complied with. | |
| 7. | Consolidated Financial Statements | |
| 7.1 | Disclosure Annex 7.1 sets out the Consolidated Financial Statements of the DME Group. | |
| 7.2 | The Consolidated Financial Statements have been prepared based upon the Individual Financial Statements. The Consolidated Financial Statements have been prepared in accordance with applicable Spanish GAAP and, in particular, in accordance with the rules and procedures governing the consolidation of accounts. The application of applicable Spanish GAAP to the Consolidated Financial Statements has been consistent with the consolidation applied in prior fiscal years. | |
| 7.3 | The Consolidated Financial Statements fairly, faithfully and accurately reflect the assets, liabilities, financial condition and the consolidated profits of the DME Group. | |
| 7.4 | From the date of the Financial Statements (i.e. December 31, 2004) until Signing: |
| a) | The DME Group companies have conducted and managed their business activities and operations in the ordinary course in a manner consistent with past practices and with those habitual in the market, and have not carried out any acts nor adopted any resolutions of an extraordinary character which could adversely affect them which has not been expressly indicated in this Agreement; and |
Page 5/28
| b) | There has been no act, circumstance or fact which arose or became evident that affects or could give rise to a Material Adverse Change in the respective assets and business activities of each of the companies of the DME Group. |
| 8. | Contracts | |
| 8.1 | All of the contracts in force to which the DME Group companies are a party (i) are valid and binding; (ii) do not breach applicable laws; (iii) have not been breached; (iv) no notice of termination has been received thereunder; (v) there is no reason to believe that such contracts will be breached or not renewed at their expiry, except as disclosed in Disclosure Annex 8.1 ; (vi) are not material loss making contracts; (vii) do not constitute with regard to any specific customer a loss making commercial relationship; and (vii) have been entered into on an arms length basis. | |
| 8.2 | None of the contracts which any of the DME Group companies are a party to contains any clauses which restrict the capacity of such companies to undertake their commercial activity in any way. | |
| 8.3 | There are no contracts with commercial agents, dealers, commission agents or similar contracts or consulting agreement, except for those listed in Disclosure Annex 8.3 . | |
| 8.4 | The entering into of this Agreement: |
| a) | Does not give rise to the right of any party to resolve or cause the early termination of any agreement entered into by any of the DME Group companies, except as disclosed in Disclosure Annex 8.4 (a) ; | ||
| b) | Does not give rise, whether directly or indirectly, to: |
| (i) | Any increase in the consideration paid by any of the DME Group companies in respect of any of the contracts entered into by the DME Group companies with suppliers or any other third parties [including the Sellers]; nor | ||
| (ii) | Any payment of any indemnity or penalty under contracts entered into by any of the DME Group companies . |
Page 6/28
Page 7/28
| 10.5 | Except as disclosed in Disclosure Annex 10.5 , the Owned Real Estate, where required, is duly registered at the corresponding public registries; the description of the Owned Real Estate as set out in such public registries is correct and coincides substantially with the actual physical characteristics of the Owned Real Estate in question (including, without limitation, location, size, boundaries, area). | |
| 10.6 | To the best of the Sellers knowledge, but without any limitation on Sellers liability if it is not true, none of the Owned Real Estate has been constructed using materials considered by competent authorities to be dangerous or prohibited (such as, without limitation, asbestos or any other material that may give rise to carbonatosis, aluminosis, etc). | |
| 10.7 | Disclosure Annex 10.7 sets out a description of all real estate leased, respectively, by certain DME Group companies, including financial leasing arrangements (the Leased Real Estate). | |
| 10.8 | All of the leasing agreements related to the Leased Real Estate are valid, in force, updated with their payments, and all parties thereto are in full compliance with their respective obligations thereunder. | |
| 10.9 | The DME Group companies do not occupy or use any real estate other than the Owned Real Estate and the Leased Real Estate. | |
| 10.10 | Except as disclosed in Disclosure Annex 10.10 , the Owned Real Estate and the Leased Real Estate are properly maintained in accordance with the use for which they have been acquired or leased and they are operated in compliance with legal requirements, permits, etc. | |
| 11. | Machinery and other Equipment Integrated into Fixed Assets | |
| 11.1 | Subject to customary title retention provisions ( Reservas de dominio ) the DME Group companies are the owners of all machinery, equipment and fittings integrated into the fixed assets (other than customer owned tooling) as well as the remaining movable assets used in or necessary to carry out the Activities of DME Group (the Tangible Assets) free and clear of all liens, encumbrances and any other rights of third parties except for those rights of third parties stated in the relevant Individual Financial Statements. |
Page 8/28
| 11.2 | All Tangible Assets are duly accounted for in the relevant Individual Financial Statements. | |
| 11.3 | The Tangible Assets are owned by the DME Group companies by valid and lawful title. | |
| 11.4 | There are no Real Rights (Derechos Reales) which affect the Tangible Assets. | |
| 11.5 | There are no Personal Rights which affect the Tangible Assets. | |
| 11.6 | The Tangible Assets are duly registered with the corresponding public registries, where applicable. | |
| 11.7 | Disclosure Annex 11.7 sets out a list of all the leased tangible assets, respectively, by certain DME Group companies , including financial leasing (leasing) or operating leasing (renting) arrangements (the Leased Movables). | |
| 11.8 | All the leasing agreements over the Leased Movables are valid, in force, updated with their payments, and both parties thereto are in full compliance with all of their obligations. | |
| 12. | Intellectual or Industrial Property; Know-how | |
| 12.1 | Disclosure Annex 12.1 sets out a list of all the deeds of title to the Intellectual or Industrial Property Rights of the DME Group companies, including all the applications the concession of which would grant an Intellectual or Industrial Property Right to any of the DME Group companies , as well as the Intellectual or Industrial Property Rights which are owned by third parties and which are used by the DME Group companies (the third party owner or owners of such Intellectual or Industrial Property Rights being shown on the Disclosure Annex), and all the Intellectual or Industrial Property Rights licensed, respectively, by DME Group companies to third parties (the third party licensee or licensees of such Intellectual or Industrial Property Rights being shown on the Disclosure Annex) . | |
| 12.2 | The entering into of this Agreement does not implicate the termination or loss of any legal title to the Intellectual or Industrial Property rights that DME Group |
Page 9/28
| has and needs to undertake the activities of the DME Group in the manner they have been undertaken to date. | ||
| 12.3 | The Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1 are duly registered with the relevant public registries, where applicable, and are fully enforceable and valid against third parties, and are according to the best of the Sellers knowledge not subject to any causes for which they may expire, be void or be avoided. | |
| 12.4 | The Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1 are updated with the payment of all annual fees, taxes, levies, charges and, in general, any payments applicable to any of them under applicable law. | |
| 12.5 | Other than specifically disclosed in Disclosure Annex 12.1 , the DME Group companies are not contractually obligated to pay, whether as a royalty, license, fee or other payment to any person in order to use any of the Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1. | |
| 12.6 | There are no claims, whether judicial or extrajudicial, nor any proceeding which could in any way affect the Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1. | |
| 12.7 | The Intellectual or Industrial Property Right set out in Disclosure Annex 12.1 are free from any charges and encumbrances, mortgages and guarantees, attachments, retentions or, in general, rights conferred to third parties. | |
| 12.8 | The Sellers have not directly or indirectly used, created, owned, or sought to register, under any title whatsoever, any industrial property, intellectual property or domain names which includes, whether alone or in combination with any other rights, one or more of the elements which constitute or are included in the Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1, or that, even without including any such elements, may prejudice, give rise to confusion with, or be associated with the Intellectual and Industrial Property Rights set out in Disclosure Annex 12.1. | |
| 12.9 | In relation to the software programs (including, as the case may be, preliminary documentation and use manuals) set out in Disclosure Annex 12.1, each DME |
Page 10/28
| Group company holds all of the rights necessary for their use by each user in the ordinary course of their activities and operations. | ||
| 12.10 | Except as disclosed in Disclosure Annex 12.10 , the DME Group companies are not infringing, misappropriating or otherwise violating and have not previously infringed, misappropriated or otherwise violated the Intellectual or Industrial Property Rights of any person and there is no infringement, misappropriation or other violation by any person of any of the Intellectual or Industrial Property Rights of DME Group companies and no infringement claim of infringement, misappropriation or other violation of Intellectual or Industrial Property has been threatened or is pending against any DME Group companies. | |
| 12.11 | The DME Group companies have taken reasonable actions as would have been taken by any diligent manager (including executing non-disclosure and intellectual property assignment agreements and filing for statutory protections where appropriate) to protect, preserve, police and maintain Intellectual or Industrial Property Rights set out in Disclosure Annex 12.1. | |
| 13. | Intangible Assets | |
| 13.1 | All the capitalized R&D expenses have been accounted for in accordance with applicable national GAAPs. | |
| 13.2 | The relevant companies of the DME Group maintain the required individual documentation for each of the projects capitalized. | |
| 13.3 | Impairment analysis has been performed regarding the present value of the investments in connection with their future contribution to income and no additional amortizations and/or provisions are required. | |
| 13.4 | The amortization period used by the DME Group is 5 years. |
Page 11/28
| 14. | Financial Assets | |
| 14.1 | The DME Group companies own, respectively, full valid and legal title to the shares ( acciones or participaciones ) of the DME Portfolio, free and clean of all liens, encumbrances, options, charges or other Third Party Rights. | |
| 14.2 | The DME Group companies, other than the Other Participations, do not have any investments in any other companies, whether Spanish or foreign companies, capital stock companies or any type of association (joint venture), temporary economic grouping, temporary union of companies, nor do they have the condition of director or have control over the management and direction of another company or entity, other than the DME Portfolio. | |
| 15. | Banks / Grants / Subsidies | |
| 15.1 | Disclosure Annex 15.1 sets out a list of all the bank accounts and deposits opened in financial institutions, respectively, by the DME Group companies. | |
| 15.2 | There are no negative balances or overdrafts in any of the bank accounts and deposits. | |
| 15.3 | Disclosure Annex 15.3 sets out a list of all the grants and subsidies received by the DME Group companies which are currently in effect or have not yet been fulfilled. | |
| 15.4 | The DME Group companies are and have always been in full compliance with the requirements of such grants or subsidies (as applicable). | |
| 16. | Loans Granted by the DME Group companies | |
| 16.1 | No DME Group company has granted or made any loans or credit arrangements to any third parties except for loans to employees in the aggregate amount below 50,000. | |
| 16.2 | Disclosure Annex 16.2 sets out a list of all the loans and credit arrangements granted among the DME Group companies. |
Page 12/28
| 17. | Inventories | |
| 17.1 | Inventories of raw materials, unfinished products and finished products are owned by valid and legal title by or are consigned to the DME Group companies and meet the needs of current operations. The terms of all consignment arrangements have been disclosed to Purchaser. | |
| 17.2 | The inventories of the DME Group companies are in an adequate state of repair in accordance with their nature. | |
| 17.3 | The inventories owned by the DME Group companies are not subject to any Real Rights. | |
| 17.4 | None of the inventories of the DME Group Companies are obsolete, other than those for which due provision has been made. The provisions for obsolete inventory and slow moving items have been made in accordance with applicable national GAAP and have considered both obsolescence and slow moving situations and in a manner consistent with prior fiscal years. | |
| 18. | Customers | |
| 18.1 | The accounts receivable are those which are set out in the Individual Financial Statements. The provisions for bad debts reflected in the Individual Financial Statements have been made in accordance with applicable national GAAP and in a manner consistent with prior fiscal years. | |
| 18.2 | All of the accounts receivable of the DME Group companies, disclosed in Disclosure Annex 18.2 , are recoverable in their entirety on the date they are respectively due and payable. No bills of exchange, factoring or other form of accounts receivable discounting has been agreed by, or with any of the DME Group companies. | |
| 18.3 | The payment conditions that the DME Group companies offer respective customers conform to the practices in the industry in which they operate and are consistent with those applied in prior fiscal years. No customer has benefited from special payment conditions. |
Page 13/28
| 18.4 | Discounts for volume purchasing (rappels) as well as any other benefits offered to customers are adequately reflected in the Individual Financial Statements of each of the DME Group companies, including, where appropriate, provisions for variation in accruals. There have been no significant modifications in the commercial discount policies compared to policies applied consistently in prior fiscal years. | |
| 18.5 | Except as disclosed in Disclosure Annex 18.5 , no customer, which accounts for more than one per cent (1%) of the sales of any of the DME Group companies has during the past 24 months threatened to terminate or terminated their relationship with any of the DME Group companies, nor has such a customer notified their intention to terminate their relationship therewith. | |
| 18.6 | All contracts between the DME Group companies and its customers are on the basis of standard purchase orders issued by the respective customers. | |
| 19. | Issuing of Obligations and Series of Debt | |
| 19.1 | None of the DME Group companies have had recourse to financing by means of issuing public debt and, in particular, have not issued any obligations (whether convertible or non-convertible), bonds, promissory notes, commercial paper, warrants, or any other credit instrument or series of debt. | |
| 20. | Debts with Financial Institutions | |
| 20.1 | Disclosure Annex 20.1 sets out all of the loans, credits and any other type of unpaid financing granted by financial and non-financial institutions to DME Group companies. | |
| 20.2 | The contracts referred to in Disclosure Annex 20.1 are in force and have not been breached. | |
| 20.3 | The DME Group companies are updated with the payment of any quotas, amortizations or interests derived from the financing agreements. |
Page 14/28
| 20.4 | None of the DME Group companies hold any off-balance sheet financial arrangements such as factoring, confirming, derivatives and any other similar financial instrument that should need to be properly disclosed and/or accounted for. | |
| 21. | Guarantees | |
| 21.1 | None of the DME Group companies are guarantors or have given any other form of guarantee or have their assets serve as collateral for any obligations of any other DME Group company or any third parties, except for as provided in Disclosure Annex 21.1 . | |
| 21.2 | Disclosure Annex 21.2 lists all the guarantees and other forms of collateral received by all DME Group companies. | |
| 22. | Suppliers/Accounts Payable | |
| 22.1 | All debts with suppliers of the DME Group companies are duly reflected in the Financial Statements in accordance with applicable national GAAP. | |
| 22.2 | Disclosure Annex 22.2 includes all the commercial paper (including bills of exchange and promissory notes) issued, granted, or accepted by the DME Group companies. | |
| 22.3 | Except as for disclosed in Disclosure Annex 22.3 , all of the DME Group companies have timely complied with their payment obligations and have not incurred any cause of default thereunder. | |
| 22.4 | All debts with suppliers correspond to the regular operations of the DME Group companies undertaken in the ordinary and usual course of their operations, resulting from the delivery of goods or rendering of services by the suppliers duly justifying the existence of such debts. Credit Agreements are in conform to practice within the industry. | |
| 22.5 | Except as disclosed in Disclosure Annex 22.5 , no supplier which accounts for more than one per cent (1%) of the acquired raw material or services of any of the |
Page 15/28
| DME Group companies has during the past 24 months threatened to terminate, terminated or altered the terms of their commercial relationship with any of the DME Group companies, nor has communicated their intention to do so. | ||
| 22.6 | There are no discounts for volume purchasing (rappels) and any other benefits that the DME Group companies have credited against their suppliers. | |
| 23. | Taxes | |
| 23.1 | All of the DME Group companies have timely complied with all legal obligations for tax matters in all competent jurisdictions in both their material and formal aspects. | |
| 23.2 | None of the DME Group companies have amended any of their tax declarations in any fiscal years not yet barred by the applicable statute of limitation. | |
| 23.3 | No amounts are owed for Taxes other than those reflected and appearing in the Consolidated Financial Statements and in the Individual Financial Statements. | |
| 23.4 | The DME Group companies have funded sufficient provisions and reserves for payment of Taxes due and not expired. | |
| 23.5 | Each of the DME Group companies have timely filed in due form all Tax returns, paid all Taxes required to be paid with such tax returns, preserved the supporting documents in relation to Taxes, and the tax authorities have not requested clarification of any such declarations. | |
| 23.6 | Disclosure Annex 23.6 sets out a list of all the fiscal tax inspections or requests by the Tax authorities to any of the DME Group companies. Other than as indicated in such Disclosure Annex, there are no inspections, proceedings, consultations or discussions pending resolutions by the tax authorities or Courts. | |
| 23.7 | The amount of economic rights of a tax nature which result from the declared tax losses, tax refunds, incentives, deductions and amortization plans which are set out in Disclosure Annex 23.7 are fully in force and in compliance with Law. The available tax credits of DME on Research & Development as of December 31, 2004 are at least equal to 13,396,876.92 million and have been declared and reflected |
Page 16/28
Page 17/28
| pricing policy as applied does not give rise to liabilities in any of such DME Group companies. | ||
| 24. | Health, Safety and Environmental | |
| 24.1 | The storage, treatment facilities and deposits where toxic, noxious, dangerous, radioactive substances, asbestos, or other hazardous materials or liquids which may affect the environment, of each of the DME Group companies are in a perfect state of use and repair, are free from any leaks or defects which may limit or affect their use in accordance with the purposes they serve, and there have been no instances of leaks, defects or spillages in the past. All facilities have been operated in full compliance with relevant health, safety and environmental legislative requirements and permit provisions. | |
| 24.2 | The DME Group companies comply with and have always complied with all applicable laws in regards to environmental matters. In particular, each of the DME Group companies complies with and has always complied with: |
| a) | All of their obligation in respect of the use, state of repair or exploitation of the facilities, productive processes, asbestos, transport of goods or products, elimination of residues or surpluses, and extraction of raw materials including the European End-of-Life Vehicles directive 2000/53/EC; and | ||
| b) | All its obligations in regards to the handling, treatment, storage, elimination or dumping of toxic, noxious, dangerous or radioactive substances, including those derived from the use of their goods and assets by third parties for which DME Group companies may be responsible. |
| 24.3 | There are not, and there have not been any claims, demands, actions, suits, proceedings or investigations (before any courts, tribunals or administrative bodies), related to environmental matters or the dumping or manipulation of toxic, noxious, dangerous or radioactive substances arising from the ownership, use, state of repair, or exploitation of the assets of the DME Group companies . | |
| 24.4 | The toxic, noxious, dangerous or radioactive substances used by the DME Group, do not produce contamination, and actions and measures have been adopted as required to avoid future contamination, whether to the assets of any DME Group companies or to those owned by third parties, including any public authorities. |
Page 18/28
| 24.5 | There is and has been no environmental contamination of soil, subsoil and groundwater resources at any Owned Real Estate or Leased Real Estate exceeding national or international references. | |
| 25. | Labour / Social Security | |
| 25.1 | The DME Group companies have hired and employed their Personnel and paid the Personnel salaries in accordance with all applicable laws in force and are up to date in the payment of their obligations with respect to the Personnel. In particular, the DME Group companies have timely complied, in the appropriate form, with their tax and Social Security obligations in respect of the Personnel. | |
| 25.2 | Except as disclosed in Disclosure Annex 25.2 , the DME Group companies do not have any private accident, life, health or other insurance contracted in favour of any members of the Personnel, and have not entered into or subscribed to any pension plans conveying or providing benefits to any Personnel. | |
| 25.3 | Except as disclosed in Disclosure Annex 25.3 , there are no obligations relating to payments in kind, compensations or other benefits (including purchase options, savings plans, incentives, or automobiles) with any members of the Personnel. | |
| 25.4 | The DME Group companies have not entered into any undertaking or agreement with the members of the Personnel other than those derived from their labour relationship. | |
| 25.5 | DMI sold in October 2004 its premises in Almussafes (Valencia) to Valautomoción S.L. This operation shall be considered as a transfer of undertakings and DME Group have complied with all the obligations under Spanish labour law, relating to the employees affected by the operation and there is no liability prior to the transfer that should appear in the three years after the transaction. | |
| 25.6 | Except as disclosed in Disclosure Annex 25.6 , none of the DME Group companies has assumed any obligations which grant any member of the Personnel the right to terminate their labour relationship in the event of a change of control or sale of a majority interest any of the DME Group companies, or the right to receive amounts or any other benefit of any nature greater than those established by law in the event of termination of their ordinary or special labour relationship. |
Page 19/28
| 25.7 | Except as disclosed in Disclosure Annex 25.7, no claims are pending or have been threatened between members of the Personnel and the DME Group companies and there are no circumstances or facts from which could arise future claims. With the exception of the information set out in Disclosure Annex 25.7, in the last six (6) months, the DME Group companies have not dismissed or taken action to terminate the employment relationship of any member of the Personnel and no key or important employee has expressed any intention to change employment due to the transactions contemplated by this Agreement or for any other reason. | |
| 25.8 | The DME Group companies comply with all applicable laws in respect of health and hygiene at the workplace, occupational health and safety, prevention of work-related accidents. All work centres have the equipment that the Law requires for the prevention of work-related accidents. | |
| 25.9 | None of the service relationships entered into by any of the DME Group companies with suppliers has given or gives rise to liabilities in any of such DME Group companies related to labour obligations of the suppliers. | |
| 26. | Permits and Licences | |
| 26.1 | The DME Group companies hold all the permits, licences and authorisations necessary for undertaking the Activities of the DME Group authorised by their respective corporate objects without any limitation. | |
| 26.2 | Except as referred to Disclosure Annex 26.2 , the DME Group companies have regularly obtained and maintain fully in force all of the aforementioned permits, licences and authorisations. Such permits, licences or authorisations do not require the undertaking of any important investments or the completion of any onerous obligations to remain in force or for their renewal. | |
| 26.3 | This Agreement shall not give rise to the default, or result in loss, amendment or modification of any permits, licences and authorisations held by the DME Group companies. |
Page 20/28
| 27. | Competition Law | |
| 27.1 | None of the DME Group companies or Sellers are part of any agreement nor have undertaken any practices which could be considered as anti-competitive pursuant to national or European Community laws, nor have they carried out any activities that could be deemed as unfair trading practices. | |
| 28. | Insurance | |
| 28.1 | Disclosure Annex 28.1 sets out a list of all the insurance policies entered into by the DME Group companies. The insurance policies subscribed by each of the DME Group companies provide cover for all the foreseeable risks derived from the Activities of the DME Group in the amounts and terms consistent with automotive industry practices in Europe. | |
| 28.2 | The insurance policies are in force and each of the DME Group companies is up to date with the payment of the insurance premiums relating thereto. | |
| 29. | Computer System | |
| 29.1 | The computers, equipment, servers, communications networks and computer facilities or hardware, as well as the computer programmes or software, used for the running and operation of the DME Group companies (Computer System) are in good working order, have received maintenance and repair to assure their good working order and do not have nor is there reason to relieve that they may have any defects that could affect their performance or limit the undertaking of the Activities of the DME Group. | |
| 29.2 | The computer programmes or software used by the Computer System are duly authorised and all the requisite licences therefore have been regularly acquired. | |
| 29.3 | The use of the Computer System by the DME Group companies has not breached nor presently breaches any rights of any third party. |
Page 21/28
| 29.4 | Disclosure Annex 29.4 lists all contracts relating to the use, access, development and maintenance of the Computer System with third parties (such as outsourcing). | |
| 29.5 | The DME Group companies possess all the necessary legal and technical documentation relating to the Computer System and have the personnel to operate the Computer System with full efficiency and normality, without interruption caused by the Transaction. | |
| 30. | Personal Data | |
| 30.1 | The DME Group companies comply with all data protection laws. | |
| 30.2 | The DME Group companies have registered files containing data of a personal nature with the Agency for the Protection of Personal Data ( Agencia de Protección de Datos ) prior to their creation. | |
| 30.3 | The DME Group companies keep files containing personal data under adequate security measures, in compliance with the Regulation on Security Measures. | |
| 31. | Insolvency | |
| 31.1 | Except as disclosed in Disclosure Annex 31.1 , none of the DME Group companies are insolvent or in a state which would require them to adopt measures to re-establish a balance between their assets and liabilities. | |
| 31.2 | Neither the Sellers nor the DME Group companies have initiated proceedings to dissolve or liquidate any of the DME Group companies, nor have they filed any petitions in bankruptcy or for the suspension of payments, nor have they requested any other measure for the protection from creditors under applicable bankruptcy and insolvency laws. | |
| 31.3 | No third party has initiated (nor notified its intention to initiate) legal actions directed at causing the dissolution or bankruptcy of the DME Group companies. |
Page 22/28
| 31.4 | No proceedings have been initiated (or threatened) to seize, execute, charge, or otherwise to collect any debts against, any of the assets of the DME Group companies. | |
| 31.5 | Except as disclosed in Disclosure Annex 31.5 none of the DME Group companies have any relationship with any customer or supplier which, to the best of the Sellers knowledge, is subject to a process of dissolution, liquidation, bankruptcy or any other insolvency proceedings. | |
| 32. | Litigation | |
| 32.1 | Except for the pending proceedings set out in Disclosure Annex 32.1 , none of the companies of the DME Group nor any Person for whose actions any of such companies are legally responsible is a party, whether as plaintiff, defendant, witness or participant, in any judicial or arbitral proceedings, whether relating to civil, contentious-administrative, criminal or economic-administrative matters (whether before the ordinary courts and tribunals, arbitral tribunals, or before administrative bodies at the national, autonomous community, municipal or other government level), nor are they a party to any claims, investigations or, more generally, any audit or inspection proceedings. | |
| 32.2 | None of the aforementioned proceedings are pending and to the best of the Sellers knowledge there is no threat that such proceedings will be initiated against any of the DME Group companies or any such Persons. | |
| 32.3 | There are no claims pending or threatened, nor, to the Sellers best knowledge, do circumstances exist that are likely to give rise to such claims, against the directors or members of the board of directors of the DME Group companies which could give rise to economic liabilities for the DME Group companies. There are no judgements or orders against any of the Sellers or DME Group companies or settlement of any proceedings or judicial investigations affecting or limiting the manner and/or capacity of the DME Group companies or their directors, to conduct the Activities of the DME Group. |
Page 23/28
| 33. | Compliance with Laws | |
| 33.1 | In respect of matters which have not been specifically described in these Representations and Warranties, the DME Group companies comply with all laws, regulations and rules applicable to them. |
Page 24/28
|
Disclosure Annex 2.7:
|
Companies where there are restricitons to transfer of shares. | |
|
|
||
|
Disclosure Annex 3.1:
|
Share capital of the DME Group companies | |
|
|
||
|
Disclosure Annex 3.2:
|
Corporate resolutions affecting share capital | |
|
|
||
|
Disclosure Annex 3.5:
|
Nihon Plast | |
|
|
||
|
Disclosure Annex 5.1:
|
Amendments of By-laws | |
|
|
||
|
Disclosure Annex 5.3:
|
Corporate Books | |
|
|
||
|
Disclosure Annex 6.1:
|
Individual Financial Statements | |
|
|
||
|
Disclosure Annex 7.1:
|
Consolidated Financial Statements | |
|
|
||
|
Disclosure Annex 8.1:
|
Contracts which may not be renewed | |
|
|
||
|
Disclosure Annex 8.3:
|
Contracts with commercial agents, dealers, etcetera | |
|
|
||
|
Disclosure Annex 8.4 (a):
|
Contracts with change of control provisiones | |
|
|
||
|
Disclosure Annex 10.1
|
Owned Real Estate | |
|
|
||
|
Disclosure Annex 10.3:
|
Real Rights affecting Real Estate | |
|
|
||
|
Disclosure Annex 10.5:
|
Circumstances and description of Real Estate | |
|
|
Page 25/28
|
Disclosure Annex 10.7:
|
Leased of Real Estate | |
|
|
||
|
Disclosure Annex 10.10:
|
Easements burdening the Owned Real Estate or the Leased Real Estate | |
|
|
||
|
Disclosure Annex 11.7:
|
Leased Movables | |
|
|
||
|
Disclosure Annex 12.1:
|
List Intellectual Property Rights; Know-how | |
|
|
||
|
Disclosure Annex 12.10:
|
Autoliv | |
|
|
||
|
Disclosure Annex 15.1:
|
Bank Accounts | |
|
|
||
|
Disclosure Annex 15.3:
|
Subsidies and grants | |
|
|
||
|
Disclosure Annex 16.2:
|
Loans and credit agreements among DME Group companies | |
|
|
||
|
Disclosure Annex 18.2:
|
Accounts receivables | |
|
|
||
|
Disclosure Annex 18.5:
|
Customers | |
|
|
||
|
Disclosure Annex 20.1:
|
Financial Loans | |
|
|
||
|
Disclosure Annex 21.1:
|
Guarantees and collaterals granted | |
|
|
||
|
Disclosure Annex 21.2:
|
Guarantees and collaterals received | |
|
|
||
|
Disclosure Annex 22.2:
|
Commercial Paper | |
|
|
||
|
Disclosure Annex 22.3:
|
Payment obligations | |
|
|
Page 26/28
|
Disclosure Annex 22.5:
|
Suppliers | |
|
|
||
|
Disclosure Annex 23.6:
|
Taxes | |
|
|
||
|
Disclosure Annex 23.7:
|
Tax credits | |
|
|
||
|
Disclosure Annex 23.13:
|
Permanent Establishment | |
|
|
||
|
Disclosure Annex 25.2:
|
Life Insurance | |
|
|
||
|
Disclosure Annex 25.3:
|
Payments in kind | |
|
|
||
|
Disclosure Annex 25.6:
|
Special arrangements | |
|
|
||
|
Disclosure Annex 25.7:
|
Labour claims | |
|
|
||
|
Disclosure Annex 26.2:
|
Permits and Licenses | |
|
|
||
|
Disclosure Annex 28.1:
|
Insurances | |
|
|
||
|
Disclosure Annex 29.4:
|
IT Systems | |
|
|
||
|
Disclosure Annex 31.1:
|
Insolvency | |
|
|
||
|
Disclosure Annex 31.5:
|
Suppliers in financial difficulties | |
|
|
||
|
Disclosure Annex 32.1:
|
Litigation |
Page 27/28
| 1. | I have reviewed this quarterly report on Form 10-Q (this Report) of TRW Automotive Holdings Corp. (the Registrant); | |
| 2. | Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report; | |
| 4. | The Registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared; | ||
| b. | Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and | ||
| c. | Disclosed in this Report any change in the Registrants internal control over financial reporting that occurred during the Registrants most recent fiscal quarter (the Registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrants internal control over financial reporting; and |
| 5. | The Registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrants auditors and the audit committee of the Registrants board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; and | ||
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting. |
|
Date: November 1, 2005
|
/s/ JOHN C. PLANT | |
|
|
John C. Plant
Chief Executive Officer and President (Principal Executive Officer) |
| 1. | I have reviewed this quarterly report on Form 10-Q (this Report) of TRW Automotive Holdings Corp. (the Registrant); | |
| 2. | Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report; | |
| 4. | The Registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared; | ||
| b. | Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and | ||
| c. | Disclosed in this Report any change in the Registrants internal control over financial reporting that occurred during the Registrants most recent fiscal quarter (the Registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrants internal control over financial reporting; and |
| 5. | The Registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrants auditors and the audit committee of the Registrants board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; and | ||
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting. |
|
Date: November 1, 2005
|
/s/ JOSEPH S. CANTIE | |
|
|
Joseph S. Cantie
Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
| 1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: November 1, 2005
|
/s/ JOHN C. PLANT | |
|
|
John C. Plant | |
|
|
Chief Executive Officer and President | |
|
|
(Principal Executive Officer) |
| 1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | ||
| 2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: November 1, 2005
|
/s/ JOSEPH S. CANTIE | |
|
|
Joseph S. Cantie | |
|
|
Executive Vice President and Chief Financial Officer
(Principal Financial Officer) |